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Résumé 
 
La maladie de Parkinson (MP) est la deuxième maladie neurodégénérative la plus 
commune. Les symptômes principalement observés chez les patients atteints de la MP sont 
la rigidité, les tremblements, la bradykinésie et une instabilité posturale. Leur sévérité est 
souvent asymétrique. La cause principale de ces symptômes moteurs est la dégénérescence 
du circuit dopaminergique nigro-striatal qui mène à un débalancement d’activité du circuit 
cortico-striatal. Ce débalancement de circuits est le point essentiel de cette thèse. Dans les 
protocoles de recherche décrits ici, des patients atteints de la MP (avant et après une dose de 
levodopa) et des participants contrôles sains ont effectué des mouvements auto-initiés ou en 
réponse à des stimulis externes pendant que l’on mesurait leur activité cérébrale en imagerie 
par résonance magnétique fonctionnelle (IRMf). Dans cette thèse, nous abordons et mettons 
en évidence quatre (4) points principaux. 
En première partie (chapitre 2), nous présentons un recensement de la littérature sur 
les cicruits cortico-striataux et cortico-cérébelleux dans la MP. En utilisant des méthodes de 
neuroimagerie, des changements d’activité cérébrale et cérébelleuse ont été observés chez 
les patients atteints de la MP comparés aux participants sains. Même si les augmentations 
d’activité du cervelet ont souvent été attribuées à des mécanismes compensatoires, nos 
résultats suggèrent qu’elles sont plus probablement liées aux changements 
pathophysiologiques de la MP et à la perturbation du circuit cortico-cérébelleux. En général, 
nous suggérons (1) que le circuit cortico-cérébelleux est perturbé chez les patients atteints 
de la MP, et que les changements d’activité du cervelet sont liés à la pathophysiologie de la 
MP plutôt qu’à des mécanismes compensatoires. 
En deuxième partie (chapitre 3), nous discutons des effets de la levodopa sur les 
hausses et baisses d’activité observés chez les patients atteints de la MP, ainsi que sur 
l’activité du putamen pendant les mouvements d’origine interne et externe. De nombreuses 
études en neuroimagerie ont montré une baisse d’activité (hypo-activité) préfrontale liée à la 
déplétion de dopamine. En revanche, l’utilisation de tâches cognitives a montré des 
augmentations d’activité (hyper-activité) corticale chez les patients atteints de la MP 
comparés aux participants sains. Nous avons suggéré précédemment que ces hypo- et hyper-
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activités des régions préfrontales dépendent de l’implication du striatum. Dans cette thèse 
nous suggérons de plus (2) que la levodopa ne rétablit pas ces hyper-activations, mais plutôt 
qu’elles sont liées à la perturbation du circuit méso-cortical, et aussi possiblement associées 
à l’administration de médication dopaminergique à long terme. Nous montrons aussi (3) que 
la levodopa a un effet non-spécifique à la tâche sur l’activité du circuit cortico-striatal 
moteur, et qu’elle n’a pas d’effet sur l’activité du circuit cortico-striatal cognitif. 
Nous montrons enfin (chapitre 4) que la levodopa a un effet asymétrique sur les 
mouvements de la main droite et gauche. À peu près 50% des patients atteints de la MP 
démontrent une asymétrie des symptômes moteurs, et ceci persiste à travers la durée de la 
maladie. Nos résultats suggèrent (4) que la levodopa pourrait avoir un plus grand effet sur 
les patrons d’activations des mouvements de la main la plus affectée. 
 
Mots clefs: Maladie de Parkinson, levodopa, circuit cortico-striatal, circuit cortico-
cerebelleux, mouvements d’origine interne, mouvements d’origine externe, IRMf  
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Abstract 
 
Parkinson’s disease (PD) is the second most common neurodegenerative disease, 
mainly manifested by tremor, rigidity, bradykinesia and postural instability, and often an 
asymmetry of symptom severity of the left and right sides of the body. The depletion of 
dopamine of the nigrostriatal pathway is the primary cause of the motor symptoms observed 
in patients with PD, leading to an imbalance in basal-ganglia prefrontal circuits. In the 
protocols described here, patients with PD before and after levodopa administration and 
healthy participants performed self-initiated (SI) and externally triggered (ET) movements 
with the left and right hand during functional magnetic resonance imaging (fMRI). In the 
chapters of this thesis, we argue and provide evidence for four main points. 
The first portion (chapter 2) provides a literature review on cortico-striatal and 
cortico-cerebellar circuit disruption in PD. Using neuroimaging techniques, changes in 
cerebral and cerebellar activity have been observed in patients with PD compared with 
healthy participants. Although increases in activity in the cerebellum have often been 
interpreted as compensatory mechanisms, we provide evidence that they are more likely to 
be related to pathophysiological changes of the disease, and the disruption of the cortico-
cerebellar circuit. In general, we argue (1) is that activity in the cerebellum is linked to the 
pathophysiology of PD. 
In the second section (chapter 3) we discuss the effect of levodopa on the patterns of 
cortical hypo- and hyper-activity in PD, as well as the activity of the putamen in SI and ET 
movements. Many studies have shown cortical hypo-activity in relation to nigrostriatal 
dopamine depletion. In contrast, some cognitive studies have also identified increases in 
cortical activity in patients with PD as compared with healthy control participants. We have 
previously suggested that cortical hypo- and hyper-activations depend on striatal 
recruitment. In this thesis, we further show that hyper-activations in the prefrontal cortex are 
not reestablished with levodopa administration. We suggest (2) that they are rather 
associated with mesocortical dopamine circuit dysfunction, and perhaps linked with long-
term dopaminergic medication administration. Furthermore, we show (3) that levodopa has 
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a non-task specific effect on the motor cortico-striatal loop, but does not affect the cognitive 
cortico-striatal circuit. 
Finally (chapter 4), we show that the effect of levodopa on movements of the left 
and right hands is not symmetrical. Previous studies have shown that in about 50% of 
patients, one side of the body is more severely affected, and this asymmetry persists 
throughout the duration of the disease. Our results suggest (4) that levodopa may have 
stronger effects on the cerebral hemodynamic patterns related to the movements of the more 
affected hand than on those of the less affected hand.  
 
 
Keywords: Parkinson’s disease, levodopa, cortico-striatal, cortico-cerebellar, self-initiated, 
externally triggered, fMRI 
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C’est le temps que tu as perdu pour ta rose qui fait ta rose si importante. 
– Antoine de Saint Exupéry, Le Petit Prince 
 
 
 
Chapter 1: Introduction 
1.1 Parkinson’s disease 
1.1.1 Shaking	  palsy	  
The first detailed description of what is known today as Parkinson’s disease (PD) 
comes from 6 cases observed by James Parkinson, published in 1817. In his depiction of 
what he termed the ‘shaking palsy’, or paralysis agitans, the disease begins slowly, such 
that it is difficult for the patient to pinpoint its precise beginning. The patient first perceives 
a slight form of weakness, with a tendency to shake, most often in one of the hands and 
arms, followed by a change in posture. Fatigue and agitation slowly spreads to the lower 
limbs.  
 
“At this period the patient experiences much inconvenience, which unhappily is 
found daily to increase. The submission of the limbs to the directions of the will 
can hardly ever be obtained in the performance of the most ordinary offices of 
life. The fingers cannot be disposed of in the proposed directions, and applied 
with certainty to any proposed point. As time and the disease proceed, 
difficulties increase: writing can now be hardly at all accomplished; and 
reading, from the tremulous motion, is accomplished with some difficulty. Whilst 
at meals the fork not being duly directed frequently fails to raise the morsel 
from the plate: which, when seized, is with much difficulty conveyed to the 
mouth. At this period the patient seldom experiences a suspension of the 
agitation of his limbs” (Parkinson, 2002). 
 
In the following stages of the disease, walking becomes increasingly difficult, sleep 
becomes troubled as tremor causes the patient to awaken, speech becomes unintelligible and 
feeding one’s self becomes virtually impossible.  
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“As the debility increases and the influence of the will over the muscles fades 
away, the tremulous agitation becomes more vehement. It now seldom leaves 
him for a moment; but even when exhausted nature seizes a small portion of 
sleep, the motion becomes so violent as not only to shake the bed-hangings, but 
even the floor and sashes of the room. The chin is now almost immoveably bent 
down upon the sternum. The slops with which he is attempted to be fed, with the 
saliva, are continually trickling from the mouth. The power of articulation is 
lost. The urine and faeces are passed involuntarily; and at the last, constant 
sleepiness, with slight delirium, and other marks of extreme exhaustion, 
announce the wished-for release” (Parkinson, 2002). 
 
There were several accounts of what could be interpreted as PD from Egyptian 
papyrus, Leonardo da Vinci, Johannes Babtiste Sagar and Rembrandt (Lees, 2007). Shortly 
after James Parkinson’s essay, Prussian diplomat Wilhelm von Humboldt (1767 – 1835) 
described the symptoms of his disease in a written correspondence with a friend: 
 
“Trembling of the hands … occurs only when both or one of them are inactive; 
now only the left one is trembling but not the right one that I am using to write – 
really odd to see … every line is starting with best intentions in large letters 
only to end … in barely legible small ones – in ageing one comes back to 
childhood's writing, because indeed childlike are these large [Latin] letters 
without connecting parts.” (Horowski, 2000)  
 
Despite this, Wilhelm von Humboldt associated his symptoms of tremor, rigidity and 
bradykinesia to common consequences of ageing (Horowski, 2000).  
 It is only in the 1860’s that this ‘shaking palsy’ was further characterized by French 
neurologists Trousseau, Charcot and Vulpian at the Salpêtrières in Paris. Charcot in 
particular recognized bradykinesia, posture (Figure 1) and gait as important signs of the 
disease, but also noted that dementia, depression, affective disorders and hallucinations 
ensued, notes that were largely ignored until the late 20th century. He subsequently rejected 
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the term ‘shaking palsy’ and attributed Parkinson’s name to the disease (Playfer & Hindle, 
2008). It took another hundred years for researchers to establish dopamine depletion as the 
source of Parkinson’s disease (PD) (Ehringer & Hornykiewicz, 1960), after which levodopa 
became the first neurotransmitter replacement treatment (Birkmayer & Hornykiewicz, 
1961). Further knowledge of mechanisms behind PD stems from the discovery of 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a by-product of meperidine synthesis. In 1976, 
23-year old chemistry graduate Barry Kidston self-injected himself with a concoction of 
meperidine and MPTP developing parkinsonism within three days. He displayed 
dopaminergic neuron degeneration in the substantia nigra at his autopsy, 18 months later. 
The contamination of this illicit drug in northern California led to numerous additional 
cases of persistent parkinsonism in young drug abusers in 1982 (Langston et al.,1983), and 
spurred research with what became the animal model of PD. 
	  
Figure 1: Illustration of PD by William Richard Gowers (1886) 
1.1.2 PD	  characteristics	  
The diagnosis of PD is not without downfalls. In a sample of 100 patients clinically 
diagnosed with PD, only 76 were found to have been correctly diagnosed post-mortem 
(Hughes et al., 1992). Most common misdiagnoses were attributed to multiple system 
atrophy, progressive supranuclear palsy, Alzheimer's disease, and cerebrovascular 
pathology. The typical neuropathological signs of PD are a loss of at least 50% of the 
melanin-containing nerve cells of the substantia nigra and a depletion of tyrosine 
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hydroxylase (Figure 2), the rate-limiting step in catecholamine synthesis (dopamine, 
epinephrine and norepinephrine). It is this neuronal loss that results in the dopamine 
depletion in PD. Another characteristic of PD is the presence of Lewy bodies (Figure 3), 
primarily consisting of alpha-synuclein agglomerations (Spillantini et al., 1997), in some of 
the remaining nerve cells (Perkin, 2008). According to Parkinson Society Canada, the 
prevalence of PD in Canada is estimated between 100 and 200 / 100,000, with an incidence 
rate of 10 to 20 / 100,000 each year; 85% of patients are over the age of 65. 
	  
Figure 2: Midbrain showing loss of melanin-containing nerve cells of the substantia 
nigra in PD (left) compared to healthy controls (right) (pathology.mc.duke.edu) 
	  
Figure 3: Lewy bodies the cerebral cortex (Love, 2005) 
 Symptoms of PD typically include tremor, rigidity, bradykinesia and postural 
disturbances. Bradykinesia mainly presents itself by the difficulty in performing tasks such 
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as lifting a fork or dressing, reduction in size of handwriting, reduced stride length and a 
stooped posture. In addition, patients have great difficulty maintaining their posture when 
pushed forwards or backwards. According to the United Kingdom PD society brain bank, 
the clinical criteria for a diagnosis of PD include bradykinesia, and either rigidity, tremor or 
postural instability (Hughes et al., 1992). Exclusion criteria consist of neurological 
conditions or drug-induced symptoms (Figure 4). Further criteria, such as unilateral onset 
and response to levodopa, can support the diagnosis of PD. The unilateral onset is 
maintained throughout the disease as symptom asymmetry; the side of the body first 
affected remains more severely affected throughout the duration of PD. This intriguing 
aspect will be the main focus of chapter 4, where we discuss the possibility that the effect of 
levodopa may be linked to disease asymmetry. 
 
Figure 4: UK clinical diagnostic criteria for PD (Hughes et al., 1992) 
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Patients also often show changes in brain imaging scans. In particular, 6-[18F]-
fluorodopa (a radioactively labeled dopamine precursor) positron emission tomography 
(PET) scans can show reduced isotope uptake in the putamen (Figure 5), particularly in the 
hemisphere that is more affected. As we will see in chapter 3, the blood oxygenation level 
dependent (BOLD) activity of the putamen and the cortical regions it communicates with 
are substantially affected in PD. 
	  
Figure 5: Fluorodopa PET in a healthy control and a PD patient (Longo et al., 2011) 
1.2 Levodopa 
Several options exist for the treatment of PD, through the alteration of the different 
metabolic steps of dopamine synthesis, release and reuptake (Figure 6). Levodopa (a.k.a. L-
dopa), the cornerstone of PD treatment, enhances dopaminergic activity by providing more 
dopamine precursor. The effect of dopamine can also be enhanced by dopamine agonists 
acting on receptors (dopamine agonists), or by inhibiting dopamine reuptake (COMT 
inhibitors). 
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Figure 6: Dopamine, metabolism and drug treatment 
COMT = Catechol-O-transferase; DA = dopamine; MAO = monoamine oxidase. Figure 
adapted from www.medscape.org 
Levodopa, or L-3,4-dihydroxyphenylalanine, is one of the most common treatments for PD. 
Unlike dopamine, it crosses the blood brain barrier, increasing the concentration of 
dopamine. Because dopamine receptors also exist in the periphery, however, the 
administration of levodopa has many adverse effects such as nausea, hypotension, 
gastrointestinal complications, hair loss and sleep disturbance. It may also be the source of 
additional cell death and, as discussed in chapter 2, lead to levodopa-induced dyskinesias 
(LIDs). 
1.3 Basal ganglia and cerebellum in PD 
1.3.1 Anatomy 
Given the importance of nigrostriatal degeneration in the pathophysiology of PD, describing 
basal ganglia anatomy and the dopaminergic pathways is crucial. Also, understanding the 
organization of the cortico-striatal circuits is fundamental for the remaining chapters. 
Finally, as will be discussed in chapter 2, the cerebellum plays an important role in the 
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pathophysiology of PD. We will therefore also introduce the cerebellum and cortico-
cerebellar connections.  
1.3.1.1 Basal	  ganglia	  
The basal ganglia are composed of the caudate nucleus, putamen, nucleus accumbens, 
subthalamic nucleus (STN), globus pallidus (GP) and substantia nigra, tightly 
interconnected regions that process information from all cortical regions. The caudate 
nucleus and putamen, forming the striatum, are deep grey matter nuclei embedded within 
the c-shaped lateral ventricles (Figure 7). The putamen and the adjacent GP (a.k.a. the 
lentiform complex) with its internal and external segments (GPi and GPe, respectively) are 
anterior to the thalamus, separated by the posterior arm of the internal capsule. The 
lentiform nucleus is covered laterally by the external capsule, claustrum, extreme capsule 
and insula. Anterior to the putamen, and joined to it at its most inferior point forming the 
nucleus accumbens, the caudate nucleus runs superiorly around the putamen, separated by 
the anterior arm of the internal capsule and forming the floor of the lateral ventricle. Inferior 
to the thalamus, as its name implies, lies the STN, just superior to the substantia nigra 
located in the midbrain. 
	  
Figure 7: Anatomy of the basal ganglia (Kandel et al., 2013) 
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1.3.1.2 Dopamine,	  dopamine	  receptors	  and	  dopaminergic	  pathways	  
Dopamine is a catecholamine neurotransmitter, synthesized from the amino acid 
tyrosine. Tyrosine hydroxylase first converts tyrosine to l-3,4-dihydroxyphenylalanine (L-
dopa); this is the rate-limiting step of dopamine synthesis. The second step is the 
decarboxylation of L-dopa to dopamine by the enzyme aromatic L-amino acid 
decarboxylase (Vallone et al., 2000). Dopamine is produced in the cell bodies of the ventral 
tegmental area (VTA) and the substantia nigra, whose axons project to different regions of 
the brain, forming several dopaminergic pathways. The three major projections are the 
nigrostriatal, meso-cortical and meso-limbic pathways (Figure 8).  
 
 
Figure 8: Dopaminergic projections showing the nigro-striatal, meso-limbic and meso-
cortical pathways (Chinta & Andersen, 2005) 
The nigro-striatal pathway runs from the substantia nigra pars compacta (SNc) to the 
dorsal striatum (putamen and caudate nucleus). It is strongly involved in movement, and its 
degeneration is the primary source of PD symptoms. The meso-limbic pathway runs from 
the VTA to the ventral striatum (nucleus accumbens), the olfactory tubercle and other parts 
of the limbic system, and is mainly involved in motivated behavior. The meso-cortical 
pathway projects from the VTA to the frontal cortex, and is involved in memory and 
learning (Le Moal & Simon, 1991). 
There are five dopamine G-coupled protein receptors, generally classified as either 
D1-like or D2-like. This classification stems from their effect on the production of cyclic 
adenosine monophosphate (cAMP) through the stimulation or inhibition of the adenylyl 
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cyclase protein (Stoof & Kebabian, 1981). The D1-like subfamily (D1 and D5), found 
exclusively post-synaptically, stimulate cAMP production, whereas the D2-like subfamily 
(D2, D3 and D4), expressed both post- and pre-synaptically, lead to an inhibition of 
adenlylyl cyclase and a decrease in cAMP production (for a review, see Beaulieu & 
Gainetdinov, 2011). D1 receptors are primarily found in the nigrostriatal, mesolimbic and 
mesocortical regions (striatum, nucleus accumbens, substantia nigra, olfactory bulb, 
amygdala and frontal cortex), as well as in the hippocampus, cerebellum, thalamic and 
hypothalamic areas. D2 receptor density is highest in the striatum, nucleus accumbens, 
olfactory tubercle, and also in the substantia nigra, VTA, hypothalamus, cortical areas, 
septum, amygdala and hippocampus. Segregation of D1 and D2 receptors has been found 
within the basal ganglia, such that the medium spiny neurons (MSNs) that project to 
different regions will selectively express one or the other. In particular, MSNs that project 
to the GPi and substantia nigra pars reticulata (SNr) express the D1 receptor, whereas a 
different group of MSNs that project to the GPe selectively express the D2 dopamine 
receptor. There is, however, a small portion (5-15%) of MSNs that express both D1 and D2 
receptors in the dorsal striatum. D1 and D2 receptors are estimated to compose the majority 
of dopamine receptors within the striatum (Levey et al., 1993); D3, D4 and D5 receptors are 
expressed at much lower levels in several cortical and subcortical regions. All receptors are 
also expressed in the periphery, such as in the kidneys, adrenal glands, gastrointestinal tract, 
blood vessels and heart (Beaulieu & Gainetdinov, 2011). 
1.3.1.3 Ganglia-­‐thalamocortical	  circuits	  
The basal ganglia and cortex are linked through a series of ganglia-thalamocortical 
circuits, referred to in this thesis as cortico-striatal loops. Five parallel circuits have been 
described by Alexander et al., namely the “motor”, “oculomotor”, “dorsolateral prefrontal”, 
“lateral orbitofrontal” and “anterior cingulate” loops. Each one of these loops consists of 
non-overlapping regions of the striatum, GP, substantia nigra, thalamus and cortex (Figure 
9). These circuits provide a topographical projection of information from functionally 
related cortical areas through the intermediate structures before being projected back to the 
cortex (Alexander et al., 1986). While the topography in these circuits is predominant, links 
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exist between these circuits at the cortical, striatal as well as thalamic levels. Furthermore, 
as discussed in the next chapter, there are important connections between the core of these 
circuits, in the thalamus, and the cerebellum. It must be noted, however, that the series of 
connections and funneling of information through these regions is part of the classical 
Albin-DeLong model (Albin et al., 1989; DeLong et al., 1990), and more complex models 
of basal ganglia function have been suggested (Bar-Gad & Bergman, 2001; Lanciego et al., 
2012). 
	  
Figure 9: The five ganglia-thalamocortical circuits as described by Alexander et al., 
1986 
The two circuits of particular interest for this thesis are the motor and “dorsolateral 
prefrontal”, or cognitive, cortico-striatal circuits. The cognitive cortico-striatal loop consists 
of projections from the dorsolateral prefrontal cortex (DLPFC) and portions of the parietal 
cortex to the head of the caudate nucleus. From the latter, projections are sent to the 
dorsomedial one-third of the GP and rostral SNr, and finally to the thalamus before 
projecting back to the DLPFC. The disruption of the cognitive cortico-striatal circuit leads 
to specific cognitive disabilities, and is thought to play a key role in the cognitive deficits 
sometimes observed in PD.  
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The motor cortico-striatal circuit is a closed loop of topographically organized 
projections between the motor cortex, premotor cortex (PMC) and supplementary motor 
area (SMA), putamen, GP, SNr, STN and thalamus. The motor loop further consists of 
direct, indirect and hyperdirect pathways. The direct pathway relays projections from the 
putamen to the GPi and then the thalamus. The indirect pathway consists of projections 
from the putamen first to the GPe, then the STN, and finally back to the GPi before relaying 
to the thalamus. Through excitatory and inhibitory connections of these two pathways, 
driven by the differential effects of D1 and D2 receptors, the direct pathway disinhibits 
thalamic activity, whereas the indirect pathway increases the inhibition of the thalamus. The 
balance between these two systems, described in detail in chapter 2, plays an important role 
in the symptomatology of PD. 
1.3.1.4 The	  cerebellum	  and	  the	  cortico-­‐cerebellar	  circuit	  
While cortico-striatal dysfunction is important in PD, cortico-cerebellar changes 
have also been reported. The nature and origins of these cortico-cerebellar alterations are 
still under debate and will be the focus of a large proportion of this thesis (chapter 2).  
The cerebellum consists of tightly packed sulci and gyri of a very regular cell 
composition, and several deep nuclei. The grey matter of the cerebellum is formed of three 
cell layers (Figure 10); the granular cell layer holds all the granule cells, interneurons and 
Golgi cells, the thin Purkinje cell layer contains the Purkinje cell bodies, and, finally, the 
molecular layer comprises of the thick Purkinje cell dendritic trees, parallel fibers, 
interneurons, stellate cells and basket cells. 
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Figure 10: Cellular layers of the cerebellum (Kandel et al., 2013) 
The cortico-cerebellar circuit consists of connections from the cerebral cortex to the 
cerebellar cortex through a series of brainstem nuclei, and feedback connections from the 
cerebellar cortex to the cerebral cortex through thalamic nuclei. Input to the cerebellum is 
carried out by two types of cells, the mossy fibers that bring cortical information from the 
pons (corticopontine and pontocerebellar projections), and climbing fibers that bring 
cortical information from the red nucleus and inferior olive. Purkinje cells from the 
cerebellar cortex then send their output to the deep nuclei of the cerebellum, which then 
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project through the red nucleus to thalamic nuclei, and finally back to the cortical region 
where information originated from, forming a closed loop. The cortico-cerebellar circuit and 
its connections with the cortico-striatal circuit are described in detail in chapter 2. 
1.3.2 Functional	  roles	  of	  the	  striatum	  and	  cerebellum	  
1.3.2.1 The	  dorsal	  striatum	  and	  cortical	  activity	  
The dorsal striatum is an essential component of the cortico-striatal pathways 
(Alexander et al., 1986). Using the Wisconsin Card Sorting Task (WCST) and the Montreal 
Card Sorting Task (MCST), Monchi et al. (2001, 2004, 2006, 2007) have been able to 
dissociate the roles of the components of the dorsal striatum, in particular those of the 
caudate nucleus and the putamen. The caudate nucleus has been shown to be involved 
different aspects of cognition such as the planning of a novel action (Monchi et al., 2006; 
Owen et al., 1996). In contrast, the putamen has been shown to be involved in the execution 
of novel actions. As discussed in the next two chapters, the recruitment of the caudate 
nucleus and the putamen lead to differences in cortical activity observed in patients with PD. 
More specifically, patients with PD don’t simply have a hypoactive cortex, as the original 
model by Albin, Young & Penney suggests (1989); they display increased cortical activity 
as compared with healthy control participants in different cognitive and motor tasks. We 
define hypo-activations in patients with PD as a decrease in cortical activity compared with 
the activity of the same region in healthy participants during the same task or contrast, and 
hyper-activations as increases in activity in cortical regions as compared with those same 
regions in healthy participants. Based on results using the WCST, MCST, and self-initiated 
(SI) and externally triggered (ET) movements (Monchi et al., 2004, 2007; Martinu et al., 
2012), we have suggested that the hypo-and hyper-activity patterns observed in PD are 
related to striatal requirement in the task at hand (Monchi et al., 2010). Moreover, in a task 
where healthy controls specifically recruit the striatum, patients with PD will show hypo-
activity of prefrontal regions. However, in tasks where healthy controls do not specifically 
require basal ganglia activity, patients with PD will show hyper-activity of prefrontal and 
parietal regions (Figure 11).  
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Figure 11: Schematic of cortical hypo- and hyper-activity in PD 
Our laboratory had previously shown that while levodopa had a significant effect on 
the structures involved in the motor cortico-striatal loop, it did not seem to affect activity of 
the cognitive cortico-striatal loop during the WCST (Jubault et al., 2009). We wanted to 
extend this concept to a motor task as well (chapter 3). But more specifically, we wanted to 
compare patients with PD to control participants to determine the effect of levodopa on the 
hypo- and hyper-activation patterns in PD. Does levodopa restore these hyper-activations to 
normal, or are they linked to the pathophysiology of PD and/or the prolonged use of 
dopaminergic medications? 
1.3.2.2 Hand	  dominance	  
According to lesion studies of right-handed subjects performed between the 1920’s 
and 1980’s, it seemed that the left hemisphere (considered to be dominant) played an 
important role in ipsilateral hand control (Mattay et al., 1998). A PET study with hand 
movements interpreted that the increase in left-hemispheric activity may be either due to a 
differential organization between the two hemispheres, or to the fact that more effort for 
right-handed subjects was necessary for movements of the left hand (Halsey et al., 1979). 
Kawashima et al. (1993) concluded that the left non-dominant hand recruited ipsilateral 
motor areas, a sign of functional asymmetry. However, Mattay et al. (1998) argued that the 
dominant hand movements used in these studies were over-learned sequences, or 
automatized, and so required less ‘conscious effort’ to perform. The non-dominant hand, 
therefore, may require more resources to perform the same movements, and thus lead to the 
recruitment of ipsilateral regions. In their study, Mattay et al. (1998) compared a simple 
task performed by the left (non-dominant) hand to a more complex task performed by the 
right (dominant) hand, and found that subjects exhibited similar ipsilateral cortical 
activations in both tasks. The authors speculated, therefore, that ipsilateral activations in 
motor tasks represent the degree to which motor movements are automatic, rather than 
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differential organization for dominant and non-dominant hand control between the two 
hemispheres.  
We have recently performed a functional magnetic resonance imaging (fMRI) study 
with healthy young adults while carrying out three conditions of a finger-moving task: a 
self-initiated (SI) button-press sequence, a computer-generated sequence, and a button-press 
repetition condition (François-Brosseau et al., 2009; this study is directly relevant to this 
thesis as we have applied the same protocol to the studies we describe, and is therefore 
included as an appendix for easy reference). We showed that the three tasks increasingly 
recruit the putamen, the repetition condition requiring the putamen the least, followed by 
the externally triggered (ET) condition, and the SI sequence generation requiring the 
putamen the most. In this particular protocol, the putamen was more involved in the 
generation of SI movements than in ET ones, and there is increasing recruitment of cortical 
motor regions with the three tasks in the same order. The main finding of this study was that 
when comparing the dominant and non-dominant hands, task demand for striatal activity 
was higher when participants used the non-dominant hand. We wanted to use this same 
protocol with patients with PD to determine, first of all, whether they showed the same 
patterns of activity and whether levodopa reestablished this discrepancy, but mainly 
whether disease asymmetry could invert this effect. This would mean that if patients were 
more severely affected on the right side of their body, would they display opposite results? 
As discussed in chapter 4, however, this hypothesis turned out to be difficult to test 
considering the recruitment restraints we faced. 
1.3.2.3 The	  cerebellum	  
For many decades, the cerebellum was considered to be involved in motor functions. 
Although Charcot had been adamant about its role in cognitive functions, this aspect has 
greatly been ignored. In the 1930's, Abbie (1934) observed that there were degenerated 
regions of the pons after major lesions to the so-called association cortices. These 
association areas are now known to be linked with the lateral hemispheres of the posterior 
lobe of the cerebellum through the pons and the thalamus (Schmahmann & Caplan, 2006). 
Additionally, Bard (1928) and Zanchetti & Zoccolini (1954) described animals that 
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developed sham rage after lesions and stimulations of the cerebellum. Even though early 
work hinted at its involvement in aspects such as emotional control and cognitive processes 
like executive functions and linguistic processing (Schmahmann & Caplan, 2006), it is only 
quite recently that experiments specifically designed to understand this involvement were 
developed. It is important to consider the cerebellum's implication in a combination of 
motor and cognitive tasks, such as the cognitive manipulation of motor sequences; a recent 
study showed that participants who perform worse at motor imagery compensated with the 
cortico-cerebellar network (Guillot et al., 2008). Taniwaki et al. (2006) showed that in 
contrast to the involvement of the cortico-striatal loop in SI movements, the cortico-
cerebellar loop is more involved in ET movements. Blouin et al. (2004), however, observed 
with PET that the cerebellum is involved in synchronized SI movements. As discussed in 
further detail in the following chapter, the involvement of the cerebellum in SI and ET 
movements is strongly dependent on the task used, partly relating to the type of planning 
involved in the individual movements. Not only do our results suggest that the cerebellum is 
preferentially involved in SI movements, we also find that levodopa has a significant effect 
on cerebellar activity. These results, discussed in chapter 2, support our hypothesis that 
levodopa increases activity in the cerebellum through connections between the cortico-
striatal and cortico-cerebellar pathways, and suggest that it is this increase that eventually 
leads to the pathophysiological involvement of the cerebellum in symptoms such as LIDs.  
1.4 Aims of this thesis 
This general aim of this thesis is to understand the effect of levodopa on the neural 
processes as measured by BOLD fMRI underlying SI and ET movements of the left and 
right hands in patients with PD. The next section (chapter 2), recently accepted in Journal 
of Behavioral Neuroscience, reviews the current literature concerning cortico-striatal and 
cortico-cerebellar circuits in PD. In this section we will discuss the compensatory and 
pathophysiological involvement of these two circuits in PD, and the role that levodopa has 
to play in LIDs, a common side-effect. The following section (chapter 3) is a research 
article published in European Journal of Neuroscience on the effect of levodopa on cortico-
striatal circuits in PD. There we demonstrate that striatal activity related to SI and ET 
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movements in PD is reduced compared with healthy controls, and that patients show hyper-
activations linked to mesocortical dopamine pathway dysfunction. Finally, in the research 
article (chapter 4) that will be submitted to Movement Disorders shortly we describe the 
differential effect of levodopa on left and right hand movements in PD. More specifically, 
we suggest that levodopa leads to significant differences in cortico-striatal regions when 
patients use their left hand and not their right hand, implying that levodopa selectively acts 
on more affected / non-dominant hand movements. 
1.5 Magnetic resonance imaging 
1.5.1 What	  is	  MRI?	  
 Magnetic resonance imaging (MRI) is an imaging technique that allows the 
visualization of internal structures. Using a powerful magnet, often in the order of 1.5 to 7 
Tesla (the earth’s magnetic strength is 0.00005 Tesla), and the magnetic properties of 
atomic nuclei in organ tissue and blood, MRI permits the imaging of the anatomical 
structures of body parts and brain function. The smallest unit of an MR image is called the 
voxel, i.e. the volumetric pixel, usually 1mm3 for an anatomical image. This is an extremely 
detailed spatial resolution when compared to other neuroimaging techniques such as 
electroencephalography (EEG) or PET (Figure 12). The temporal resolution of MRI is <1s 
(fMRI) to minutes (MRI). Although it is far from the temporal precision of EEG, MRI 
provides an adequate balance of spatial and temporal resolutions for a wide range of 
physiological and pathological studies. 
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Figure 12: Spatial and temporal resolution of neuroscience techniques (Ward, 2006) 
1.5.2 History	  
 The development of the MRI technique was made possible by Wolfgang Pauli’s 
observation, in 1924, that atomic nuclei (e.g. hydrogen) spin at specific frequencies and 
have a magnetic moment. When placed into a surrounding magnetic field, atomic nuclei 
align themselves with the field, a phenomenon referred to as relaxation time. As Isidor Rabi 
demonstrated in 1937, if a surrounding magnetic field oscillates at the same frequency as 
the atomic nucleus, the latter would absorb energy from the field, just like pushing a 
pendulum at the correct moment. This phenomenon was named magnetic resonance, and the 
frequency that has the most effect on the atomic nuclei in question is referred to as the 
resonant frequency. Just as the swing of a pendulum is highly dependent on gravity, the 
resonant frequency is highly dependent on the static magnetic field. In 1946, Edward 
Purcell and Felix Bloch independently developed experiments that tested the resonant 
frequency of solid matter (wax paper) and water. Bloch’s experiment in Physical Review 
involved a transmitter coil and a detector coil that recorded the energy, or nuclear resonance, 
absorbed by the sample of water. Nuclear magnetic resonance (NMR) is still the basis of all 
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MRI acquisitions today. The term ‘nuclear’ was eventually dropped due to its negative 
connotations with health, and magnetic resonance imaging was adopted in its stead. 
After the observation that water atomic nuclei had different relaxation times 
depending on their surrounding tissue, the medical application of NMR was clear. If the 
measure of resonant frequencies of atomic nuclei could be transformed into images, one 
could potentially distinguish between different types of tissue. The simple detection of 
emitted energy from atomic nuclei from an oscillating magnetic field, however, lacked 
spatial information. In 1972, Paul Lauterbur suggested that if the strength of the static 
magnetic field varied across space, the resonant frequency detected could give information 
about its location. In 1976, using an electromagnetic pulse and rapidly changing field 
gradients, Peter Mansfield developed the echo-planar imaging used today to record images 
in a fraction of a second, making the acquisition of images of humans possible.  
 
1.5.3 Magnets	  and	  coils	  
The MR scanner consists of several main components. The first is a wire wrapped in 
tight loops (a solenoid), forming the principal magnet (Huettel, 2004). The electrical current 
runs through this solenoid generating the static magnetic field, B0. The second important 
component is the radiofrequency antenna, placed directly around the item being scanned, is 
composed of two electromagnetic coils: a transmitter and a receiver. This antenna generates 
the electromagnetic field at the atomic nuclei’s resonant frequency, and records the energy 
released (in the radiofrequency portion of the electromagnetic spectrum). Contrary to the 
static magnetic field, these coils are turned on and off during image acquisition. When 
placed in a static magnetic field, atomic nuclei align themselves with the field in what is 
referred to as relaxation time. The radiofrequency coils send pulses that disturb this 
equilibrium, exciting the atomic nuclei. Following the pulse, it is the release of the absorbed 
energy and the return to baseline, or relaxation, that defines the magnetic resonance (MR) 
signal. 
The third important components of the MR scanner are the gradient coils. These are 
three sets of coils that will cause a transient gradient in the magnetic field in the x, y, and z 
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directions, one after the other. The controlled changes in magnetic field give the MR signal 
spatial information, in that different locations have a different contribution to the MR signal. 
An MR signal that codes spatial information about the resonating atomic nuclei permits the 
reconstruction of spatial frequency data into image-space data. Through mathematical 
manipulations (an inverse Fourier transformation), one can generate 2D images from the 
recorded MR signal. A slice-by-slice acquisition of 2D images can finally be reconstructed 
into a 3D volume encompassing the entire structure being scanned, e.g. a participant’s head. 
1.5.4 Hemodynamics	  
As different brain regions become involved in specific tasks, the energy consumed 
and therefore the demand for oxygen increases. The imaging of brain function is based on 
blood flow and the magnetic properties of hemoglobin. More specifically, water molecules 
in oxygenated hemoglobin have no magnetic moment, but deoxygenated hemoglobin has 
unpaired electrons and a significant magnetic moment; it is paramagnetic. In MR sequences 
sensitive to the changes in spin caused by deoxygenated blood, there will be a drop in MR 
signal. When measuring the BOLD response, however, what we observe is an initial dip 
followed by a strong increase in MR signal (Figure 13). One interpretation of this 
phenomenon is that when a region becomes more active and begins consuming oxygen, an 
excess of oxygenated blood flushes the region and displaces the deoxygenated hemoglobin, 
causing the rise in MR signal.  
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Figure 13: Model of the hemodynamic response 
Figure adapted from BOLD imaging, Radiopaedia, BOLD imaging, www.radiopaedia.org 
It is important to realize, when performing MRI experiments, that the changes in 
signal observed on a functional acquisition are a physiological phenomenon that correlates 
with changes in blood flow, which correlates with energy consumption of the underlying 
neurons, and which itself correlates with neuronal activity. It is not a direct measure of 
cellular activity; therefore interpretations of underlying cognitive processes have to be made 
with this in mind. The hemodynamic response is also very slow. The peak of the response 
occurs 4 to 6 seconds after the stimulus and the consequent neural response, and only 
returns to baseline after 12 to 14 seconds. This has important implications for the design of 
fMRI experiments. 
1.5.5 Experimental	  design	  
In order to answer a scientific question, a proper experimental design needs to be put 
in place. Specific hypotheses require specific dependent and independent variables. 
Additionally, in order to be able to make interpretations on neural processes involved in 
specific tasks, the experimental condition has to be compared to an adequate control, so that 
the comparison between the two can most accurately test the hypothesis in question. An 
fMRI protocol consisting of a motor or cognitive task will therefore usually consist of a 
timeframe with at least two alternating conditions. Subsequent analyses are performed to 
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correlate the hemodynamic activity (i.e. the dependent variable) involved in each condition, 
and the difference in the dependent variable between the experimental condition and the 
control condition provide an answer to the question as precisely as possible. Because the 
hemodynamic response is slow, researchers first developed the blocked design, which 
separates the different conditions in the distinct sections of an extended period of time 
(Figure 14), ranging easily from 15 to 30 seconds:  
 
Figure 14: Schematic of a blocked design, with alternating conditions A and B 
The blocked design paradigm is a powerful method that involves a sustained 
hemodynamic response, giving maximal amplitude of the BOLD response. Some questions 
cannot be answered by using the blocked design. For example, comparing correct and 
incorrect responses, or measuring the response associated with an “oddball” task involves 
events of a very short duration. Event-related paradigms are more appropriate for such 
experiments. They involve brief stimulus presentations presented randomly throughout the 
duration of the scan, with an inter-stimulus interval between each. Although this method 
does not allow the hemodynamic response to reach its maximum amplitude, it is based on 
the assumption that short stimuli will evoke a transient change in neural activity. In a 
situation where participants need to make responses to the events, this method allows the 
researcher to remove events with incorrect responses, or to make a comparison between 
them. The choice of experimental design is crucial to the questions that stem from the 
research hypothesis. One must ascertain that there are no confounding variables that would 
correlate with the variables of interest. 
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Chapter 2: Pathophysiology versus compensation 
 
 The first article presented in this thesis is a review that has recently been accepted 
for publication in a special issue on controversies in PD in Behavioral Neuroscience. Our 
preliminary data indicated that in patients with PD, activity in the cerebellum was increased 
after levodopa administration. Some studies have argued for the potential compensatory role 
of the cerebellum in PD pathology (Glickstein & Stein, 1991; Palmer et al., 2009a). If 
levodopa re-established cerebral activity to patterns observed in healthy controls, it should 
cause a reduction in activity instead. We wanted to examine more closely the role of the 
cerebellum in PD. In reviewing the literature we realized that there were two possible 
explanations for cerebellar changes in activity in PD, which are not necessarily mutually 
exclusive. We have found more convincing evidence, however, that changes in activity in 
the cerebellum are more closely linked with pathophysiology than compensatory 
mechanisms, and that many studies suggesting that the cerebellum is involved in 
compensation are inconclusive. In the following chapter we introduce in greater detail the 
cortico-striatal and cortico-cerebellar circuits, and provide evidence that the cerebellum may 
also be strongly affected by PD pathology and/or treatment. We also discuss the effect of 
levodopa on cerebellar activity, supported by our own results. 
 
Cortico-striatal and cortico-cerebellar circuits in Parkinson’s disease: pathophysiology 
or compensation? 
Martinu, K. & Monchi, O. 
 
Accepted for publication in Behavioral Neuroscience in September 2012 
 
Abstract 
The basal ganglia and the cerebellum are anatomically and functionally linked to the 
cerebral cortex through a series of well-established circuits. The disruption of dopaminergic 
projections in PD leads to an imbalance within these circuits, leading to motor and cognitive 
symptoms. The cortico-cerebellar network has often been viewed as a compensatory 
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network, helping the dysfunction of the cortico-striatal circuits in PD. However, evidence 
for this compensatory role is scarce; most changes in cerebellar activity could equally be 
attributed to pathophysiological changes underlying PD. This paper will review the anatomy, 
interaction and function of the cortico-striatal and cortico-cerebellar circuits, the 
pathophysiological, metabolic and functional changes observed in PD, as well as the effect 
of levodopa and deep brain stimulation (DBS) on these changes. We will use this 
framework to discuss the pathophysiological and compensatory mechanisms behind cortico-
striatal and cortico-cerebellar circuit activity in PD. 
 
Keywords: Parkinson’s disease, Cerebellum, Striatum, Compensation, Levodopa 
 
Introduction 
 
PD is a debilitating neurodegenerative illness associated with the loss of 
dopaminergic neurons of the substantia nigra. Patients classically suffer from motor 
symptoms such as tremor, rigidity and bradykinesia, although cognitive deficits in executive 
functioning, memory, language, and visuo-spatial processing are also pervasive (Taylor & 
Saint-Cyr, 1995). The cortex, thalamus, basal ganglia and cerebellum form a series of 
anatomically and functionally segregated circuits sub-serving a multitude of cognitive and 
motor functions. The disruption of these circuits through the degeneration of dopaminergic 
neurons in the substantia nigra leads to widespread changes in brain activity and 
connectivity. It is not yet known whether these extensive neural changes are strictly the 
result of PD pathophysiology or, alternatively, are manifestations of compensatory 
mechanisms in response to the disease. It has been suggested that the recruitment of cortico-
cerebellar networks is one possible compensatory mechanism for the generation of 
movement in PD (Rascol et al., 1997, Palmer et al., 2009a), such as SI and ET movements. 
However, many of the changes in the cortico-cerebellar circuits may be the result of 
disruptions caused by PD or by the prolonged used of dopaminergic medication. In this 
review we will suggest that the pathophysiology behind changes in cerebral and cerebellar 
activity cannot be ignored, and that future research will be necessary to disentangle these 
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two alternative hypotheses. To this end, we will first describe the anatomy and function of 
the cortico-basal ganglia and cortico-cerebellar circuits, as well as the pathophysiological, 
metabolic and functional changes in these circuits as a result of the disease. We will then 
discuss the effect of levodopa and its side effects in the treatment of PD, DBS, and provide 
suggestions for future research that may help distinguish between compensatory and 
pathophysiological mechanisms.  
 
Cortico-basal ganglia circuits 
 
Anatomical connections 
It is well established that motor, sensory and association areas of the cortex are 
extensively connected with specific subdivisions of the basal ganglia to form a series of 
‘basal ganglia-thalamocortical’ circuits. Several distinct circuits have been described, 
including the motor, oculomotor, limbic and associative circuits (Alexander et al., 1986). 
These functionally and anatomically segregated pathways mainly relay information from 
functionally related cortical regions, the striatum, pallidum and substantia nigra and the 
thalamus. Understanding the connections within and between these circuits is crucial for 
procedures such as DBS, as an intervention in one area will have specific effects across a 
wide range of areas (Wichmann & DeLong, 2011). In the motor basal ganglia-
thalamocortical circuit, somatotopically organized information from the somatosensory, 
motor, premotor and supplementary motor cortices is projected through the putamen, STN, 
GPi, GPe and SNr to the ventrolateral nucleus of the thalamus. The thalamus finally 
projects back to the cortex, forming a closed loop of tightly interconnected regions  
The motor cortico-striatal loop can further be divided into ‘direct’ and ‘indirect’ 
pathways, by which competing processes between the putamen, GP, STN and SNr 
determine overall thalamic activity (Alexander et al., 1990). Specifically, the direct pathway 
connects the striatum to the GPi/SNr by a single inhibitory projection. By contrast, the 
indirect pathway connects the striatum to the GPi via inhibitory projections to the GPe and 
the STN and ultimately excitatory connections to the GPi/SNr. An overall output is finally 
sent from the GPi/SNr to the thalamus; the direct pathway causes the striatum to disinhibit 
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the thalamus, whereas the indirect pathway causes the striatum to inhibit thalamic activity 
(Figure 15). The signals from the direct and indirect pathways create a balance of opposing 
contributions, allowing movement to be regulated via thalamocortical connections. 
However, these pathways are not entirely independent as evidence suggests that there are 
synaptic connections between the direct and indirect motor cortico-striatal pathways (Yung 
et al., 1996).  
 
Figure 15: Schematic of cortico-basal ganglia circuits in healthy individuals 
Solid lines represent excitatory connections, dashed lines represent inhibitory connections. 
There is also evidence for additional connections directly from the cortex to the STN 
(Monakow et al., 1978), referred to as the ‘hyperdirect’ pathway. One possibility would be 
that signals to the thalamus are first modulated by the inhibitory hyperdirect pathway, 
followed by the excitatory direct pathway, and finally by the inhibitory indirect pathway 
(Nambu et al., 2002). The STN, reflecting the organization of the basal ganglia into motor 
and associative and limbic portions, functions as a major relay station and modulator in the 
processing of cortico-striatal information (Hamani et al., 2004).  
 
Neuromodulators 
Dopamine is a prominent neurotransmitter in the basal ganglia, and, among other 
functions, plays a major role in movement through the cortico-striatal pathway. Although 
	  	  	  	  	  
28	  
many different neurotransmitters are implicated in brain circuitry and PD, this review will 
focus on dopamine in particular. Dopaminergic projections are sent from the substantia 
nigra to the striatum, forming the nigrostriatal pathway. Additional dopaminergic 
projections run from the VTA to the nucleus accumbens (mesolimbic pathway) or frontal 
cortex (mesocortical pathway). In the context of the motor cortico-striatal circuit, dopamine 
has a contrasting effect on the direct and indirect pathways through a differential effect on 
D1 and D2 receptors (Gerfen et al., 1990; DeLong & Wichmann, 2007). Specifically, 
dopamine has a net inhibitory effect on the indirect pathway and a net excitatory effect on 
the direct pathway. The end result is that dopamine effectively favours the direct pathway, 
and its depletion or excess creates an imbalance in the two circuits, affecting activity in 
most cortical regions through the different cortico-striatal loops. This ultimately leads to the 
movement-related difficulties observed in different patient populations.  
 
Cortico-cerebellar circuit 
 
Anatomical connections 
The cortico-cerebellar circuit is similarly organized into functionally segregated 
pathways that connect regions of the cerebellar cortex with the cerebral cortex. Lateral 
portions of the cerebellar cortex send projections, via the dentate nucleus, to the thalamus, 
which in turn projects to specific cortical areas (Figure 16). Retrograde transneuronal 
transport methods using neurotropic viruses have shown that these cortical areas include the 
motor, premotor, oculomotor, prefrontal cortex (PFC) and posterior parietal cortex (PPC) 
with minimal overlap between different termination sites (Clower et al., 2001; Middleton & 
Strick, 2001; Strick et al., 2009). Projections from the cortex back to the lateral cerebellum 
pass either through the pons or the red nucleus and inferior olive (Leiner et al., 1989). 
Furthermore, the segregation of connections to the cerebral cortex is maintained in the 
cerebellar cortex (Kelly & Strick, 2003), such that the separate compartments of the 
cerebellum form closed anatomical loops with the specific cortical region they send 
projections to and receive input from (Strick et al., 2009). 
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Figure 16: Schematic of the cortico-cerebellar circuit 
Wave: cortex; DN: dentate nucleus. 
 
The cerebellar cortex is organized into very regular molecular, Purkinje and granular 
cell layers, suggesting that the type of information processing in the cerebellar cortex is 
mainly related to its associations with different cortical regions, rather than local circuitry 
(Ramnani, 2006). The dentate nucleus seems to consist of distinct sections that process 
motor and non-motor information (Dum & Strick, 2003), with the non-motor portion of the 
dentate nucleus substantially larger than the motor section (Matano, 2001). In fact, two 
main circuits have been described, notably the ‘motor’ loop that projects from the motor 
and PMC to the dorsal part of the dentate nucleus, and the ‘prefrontal’ loop that connects 
Brodmann area 9/46 and the ventral dentate nucleus (Glickstein et al., 1985; Orioli & Strick, 
1989; Schmahmann & Pandya, 1995; Kelly & Strick, 2003). This segregation of motor and 
non-motor connections from the dentate nucleus is maintained in the cerebellar cortex, with 
separate locations being connected to areas such as the primary motor cortex and area 46 
(Strick et al., 2009). Diffusion tensor imaging (DTI) examining the distribution of fibers in 
the cerebellar peduncle in humans and macaque monkeys in vivo has revealed that the 
majority of fibers in the macaque consist of motor fibers, whereas humans have a much 
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larger prefrontal component (Ramnani et al., 2006). Thus, the cerebellum, similar to the 
basal ganglia, has underlying connections linked to both motor and cognitive functions 
(Strick et al., 2009).  
 
Neuromodulators 
Although the cerebellum receives mainly noradrenergic and serotonergic projections, 
there is also evidence for dopamine, acetylcholine and histamine (Schweighofer et al., 
2004). In particular, dopaminergic neurons from the rat’s VTA send projections to the 
cerebellar cortex (Ikai et al., 1992). In fact, animal studies have shown that DARPP-32, a 
dopamine and cAMP regulated phosphoprotein of M(r) 32 kDa, is expressed in the 
cerebellar’s Purkinje cells and may be involved in the regulation of long term depression 
(LTD; Alder & Barbas, 1995). The cerebellum was long thought to contain almost no 
dopamine D2/D3 receptors compared with the striatum (Hall et al., 1994). Consequently, 
D2/D3-receptor binding [11C]raclopride PET studies have sometimes used the cerebellum as 
a reference tissue for raclopride binding (e.g. Hilker et al., 2003; Ko et al., 2008; Steeves et 
al., 2009). Other evidence suggests, however, that the cerebellar cortex contains a high 
density of dopamine D3 receptors that may help regulate locomotor activity and provide a 
form of cellular modulation by dopamine (Sokoloff et al., 1990; Bouthenet et al., 1991; 
Barik & de Beaurepaire, 1996; Schweighofer et al., 2004). The presence and the modulation 
by dopamine imply that cerebellar activity may be affected by dopamine depletion in PD, 
and consequently by dopamine replacement therapy. 
Dopamine, norepinephrine (a.k.a. noradrenaline) and epinephrine are 
catecholamines synthesized from tyrosine through a series of metabolic events (Nagatsu et 
al. 1964). It is important to note that there are substantial noradrenergic projections to the 
cerebellum from the locus coeruleus and VTA, regions significantly affected in PD 
(Hornykiewicz, 1975; Szot et al., 2012). Decreases in cerebellar norepinephrine levels have 
been shown in PD patients (Kish et al., 1984) as well as the MPTP monkey model of PD 
(Pifl et al., 1991). 
 
Synaptic connections between cortico-striatal and cortico-cerebellar loops 
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Initially, the cortico-striatal and cortico-cerebellar circuits have been considered to be 
anatomically distinct. In particular, the cerebellum and basal ganglia relay information to 
separate regions of the thalamus (Asanuma et al., 1983) and retrograde labeling using the 
herpes simplex virus has shown that the segregation of cortico-striatal and cortico-cerebellar 
circuits remains at the level of the cortex, cerebellum and dentate nucleus as well as in the 
thalamus and the substantia nigra [for a review, see (Middleton & Strick, 2000)]. However, 
more recent evidence suggests there are direct connections between the cortico-striatal and 
cortico-cerebellar circuits (Bostan & Strick, 2010). Studies using the rabies virus and 
retrograde labeling in non-human primates report bi-synaptic projections from the STN to 
the cerebellar cortex via pontine nuclei (Bostan et al., 2010) and tri-synaptic connections 
between the GPe and the dentate nucleus (Hoshi et al., 2005). A synaptic link between the 
cortico-striatal and cortico-cerebellar pathways implies that changes in one circuit may 
affect the other circuit. This has implications for diseases such as PD as connections 
between the cortico-striatal and cortico-cerebellar circuits mean that dynamic fluctuations in 
the cortico-striatal pathway related to disease pathophysiology can affect the activity 
observed in the cortico-cerebellar pathway.  
 
Cortico-striatal and cortico-cerebellar loop function 
 
Functional MRI studies have provided evidence of cortico-striatal involvement in 
movement planning, initiation, motor learning, timing control and their modulation by task 
complexity (Alexander et al., 1990; Rao et al., 1997; Boecker et al., 1998; Mattay et al., 
1998; Jenkins et al., 2000; Cunnington et al., 2002; Taniwaki et al., 2003; Elsinger et al., 
2006; Purzner et al., 2007; Boecker et al., 2008; Doyon et al., 2009; Francois-Brosseau et 
al., 2009). Furthermore, single-cell recording studies in monkeys demonstrated the 
involvement of the putamen and caudate nucleus in SI and ET movements, where some 
neurons would respond to SI movements only, and others for both SI and ET movements 
(Romo et al., 1992; Romo & Schultz, 1992). Activity in the substantia nigra has been 
observed for both internally and externally guided actions and movements (Monchi et al., 
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2006; Boecker et al., 2008). Taken together, these findings suggest that the striatum is 
especially involved in the planning and the execution of novel and SI movements (Elsinger 
et al., 2006; Boecker et al., 2008).  
Consistent with the motor and non-motor anatomical connections of the cortico-
cerebellar pathway, the cerebellum consists of specific topographically organized 
compartments used for the integration of motor and non-motor functions (e.g. emotion, 
working memory and language) (Stoodley & Schmahmann, 2009). There are also task-
dependent and task-independent neurons in the dentate nucleus that respond to the planning 
phase of internally and externally cued movements (Middleton & Strick, 2000). Functional 
MRI studies have additionally demonstrated that slightly different regions of the dentate 
nucleus are activated during movement planning and execution (Kim et al., 1994), and that 
the lateral cerebellum is involved in the planning phase (Boecker et al., 2008). When 
looking at the temporal involvement of motor regions in the planning and execution of 
simple self-paced movements, both cortical and cerebellar regions show gradual spatial and 
temporal changes (Hulsmann et al., 2003); activity within the cerebellum shifted spatially in 
the same time-frame as the activity shift from the anterior cingulate cortex to the SMA and 
the PMC.  
The acquisition of complex motor skills can be divided into motor sequence learning 
and motor adaptation. Motor sequence learning consists of the gradual performance of a 
specific sequence of movements, whereas motor adaptation denotes the ability to 
compensate for changing environments (Doyon & Ungerleider, 2002; Doyon et al., 2003; 
Doyon & Benali, 2005). Doyon and his colleagues have proposed that both types of 
learning initially recruit regions within the cortico-striatal and cortico-cerebellar pathways. 
When learning is more advanced and the subject has reached asymptotic performance, 
however, there is a shift of representation between the regions within the cortico-striatal or 
the cortico-cerebellar loop, depending on the type of learning. At that stage, sequence 
learning relies mostly on the cortico-striatal loop, while motor adaptation depends 
predominantly on the cortico-cerebellar loop (Doyon et al., 2003; Doyon et al., 2009). It has 
been shown that motor learning is affected even in early PD (Shin et al., 2003), with 
considerable changes in brain activity (Mentis et al., 2003). Since this framework allows a 
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clear distinction between the cortico-striatal and cortico-cerebellar pathways functionally, it 
holds great promise for future research that aims to address whether or not the cortico-
cerebellar circuit is recruited in PD to compensate for cortico-striatal deficiency. 
 
Parkinson’s disease  
 
Motor and cognitive symptoms can arise in parallel with the disruption of normal 
function of the putamen and caudate nucleus, with almost complete dopamine depletion 
seen in the putamen (Kish et al., 1988). In PD patients, nigrostriatal dopamine depletion 
leads to a net increase in STN and GPi discharge, but a decrease in GPe discharge, creating 
an imbalance in the direct and indirect pathways (DeLong & Wichmann, 2007) (Figure 17). 
Specifically, the indirect pathway becomes hyperactive and the direct pathway becomes 
hypoactive, resulting in an excess of inhibitory output from the GP, leading to bradykinesia 
and rigidity (Bergman et al., 1994). In addition, according to the functional deafferentation 
hypothesis, the increase in GPi tonic activity leads to cortical inhibition (Albin et al., 1989). 
The depletion of dopamine in the motor system is associated with important changes in the 
entire brain that gradually spread from the brainstem to the cortex (Braak et al., 2003). 
These changes effectively result in autonomic dysfunction, olfactory and sleep disorders, 
emotional impairment and cognitive deficits. 
 
Figure 17: Schematic of the interaction between cortico-striatal and cortico-striatal 
circuits in PD (Martinu & Monchi, 2012) 
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Arrow weight represents increases and decreases of synaptic output in PD as compared 
with healthy individuals. Solid lines represent excitatory connections, dashed lines 
represent inhibitory connections, double lines represent a mixture of inhibitory and 
excitatory projections. The change in synaptic output in the cortico-cerebellar circuit is the 
hypothesized effect in tasks that involve the cortico-striatal pathway. Note that the nature of 
connections to and from the cerebellum are still under debate. 
 
Lesions of the cerebellum also cause a range of deficits, from motor to non-motor 
symptoms, depending on the location of the lesion (Strick et al., 2009). It has been shown 
that changes in the cortico-cerebellar pathway are involved in resting tremor, as well as the 
suppression of tremor during voluntary movements (Deuschl et al., 2000). Lesions of the 
superior cerebellar peduncle seemed to alleviate parkinsonian tremor (Cooper, 1956), 
although the removal of cerebellar lobes does not seem to treat tremor consistently. Recent 
work with macaque monkeys has shown a correlation between persistent Purkinje cell 
activity in the cerebellum and dopaminergic degeneration (Heman et al., 2012). Deep brain 
electrode recordings in PD and essential tremor patients (Pedrosa et al., 2012) as well as in 
the MPTP model of PD (Guehl et al., 2003) also indicate that there are tremor-related cells 
in the thalamus. It has been suggested that it is the disruption of competitive balance 
between cerebellar and basal ganglia output that leads to certain types of tremor in PD 
(Stein & Aziz, 1999; Deuschl et al., 2000). More specifically, Helmich et al. hypothesize 
that the disruption of the cortico-striatal pathway sends transient fluctuating signals to the 
cortico-cerebellar circuit leading to tremor (Helmich et al., 2011). In accordance, a recent 
voxel-based morphometry study has shown a decrease in cerebellar gray matter in patients 
with PD that present with tremor (Benninger et al., 2009).  
 
Metabolic alterations in PD 
 
Some of the first functional neuroimaging studies in PD were aimed at 
understanding the change in metabolism and activity fluctuations. Fluorodeoxyglucose (18F) 
(FDG) PET results suggested a decreased global metabolism, with additional decreased 
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inferior parietal an increased basal ganglia metabolism (Kuhl et al., 1984; Martin et al., 
1984; Schapiro et al., 1993). Using a scaled subprofile model (SSM) to study spatially 
distributed networks (Moeller & Strother, 1991), Eidelberg et al. (1994) were able to detect 
a pattern of metabolic increases and decreases related to PD pathology, the PD-related 
pattern (PDRP), reproducible across parkinsonian patients and tomographs (Moeller et al., 
1999). Although there was no difference between healthy control and PD patient global 
brain metabolism levels, authors found a major topographic profile consisting of metabolic 
decreases in the lateral frontal, paracentral and parietal association cortices, and increases in 
the lentiform nucleus, thalamus, pons and cerebellum (Eidelberg et al., 1994). Furthermore, 
the individual topographic profile score correlated with the patients’ Hoehn & Yahr stage 
and motor unified Parkinson’s Disease rating scale (UPDRS) symptom severity score. The 
PDRP is also strongly associated with STN activity, and lesioning the STN in return affects 
the PDRP activity (Su et al., 2001). The PDRP can be detected at an individual level before 
the onset of symptoms, giving it great potential for early diagnosis. The metabolic increases 
and decreases of this topographic profile accentuate with disease progression; longitudinal 
data show an increase in metabolism in the pedunculopontine nucleus, STN, GPi and motor 
cortex and a decrease in metabolism in prefrontal and parietal association cortices over 
disease progression (Huang et al., 2007). Furthermore, Mure et al. (2011) recently used 
FDG PET to describe a PD tremor-related pattern (PDTP) that plays an important role in 
parkinsonian tremor, and which consists mainly of structures involved in the cortico-
cerebellar pathway. 
The altered patterns of brain metabolism could reflect a form of network adaptation 
to disease pathology (Eidelberg, 2009). However, results from these methods do not allow 
the distinction between compensatory mechanisms and pathological consequences of circuit 
imbalance. Because the structures implicated in the PDRP and PDTP are linked through the 
cortico-striatal and cortico-cerebellar circuits, fluctuations in one will cause fluctuations in 
the other, resulting in widespread changes in metabolism that increase as the disease 
progresses.  
 
Hypo- and hyper-activations in PD 
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Many neuroimaging studies have reported hypo- and hyper-activations in patients 
with PD compared with healthy controls during motor and cognitive tasks. In this section 
we will focus on the basis of these patterns, and whether hyper-activations in the cerebellum 
in particular can be attributed to compensatory mechanisms.  
The classic model of motor deficits in PD (Albin et al., 1989) depicts that the 
increased inhibitory drive to the thalamus leads to a decreased excitatory drive to the 
cerebral cortex. Consistent with this model, observations of original functional 
neuroimaging studies in PD indeed found decreases in motor, premotor, and PFC activity 
(Playford et al., 1992). A series of studies, however, later showed overactivity in certain 
cortical regions (Sabatini et al., 2000; Haslinger et al., 2001), indicating that patients with 
PD do not simply have a hypoactive cortex. Models have been suggested to account for 
these changes in activity; one proposition was that hypo- and hyper-activity patterns in PD 
were related to a distinction between motor and cognitive tasks, respectively (Mattay et al., 
2002). Based on our previous work with set-shifting tasks (the MCST and WCST), we have 
observed that the increases and decreases in cortical activity seen in patients with PD are 
related to whether the striatum is necessary for the task at hand or not (Monchi et al., 2004; 
Monchi et al., 2007; Monchi et al., 2010), rather than whether the basis of the task is motor 
or cognitive. More specifically, we have observed a decrease in activity in the prefrontal 
regions of patients with PD off medication compared with control participants for tasks that 
require the striatum in healthy controls (e.g. planning a set-shift; hypo-activation). In 
contrast, when performing tasks that do not require the striatum (e.g. task execution without 
changes in rules) in healthy controls, patients with PD showed significant prefrontal and 
parietal increases in activity (hyper-activation) (Monchi et al., 2007). Moreover, in a given 
task where healthy participants recruit the striatum, patients with PD will show a reduction 
in cortical activity as the model by Albin, Young and Penney suggests. On the other hand, 
in tasks where healthy participants do not recruit the striatum, patients with PD present 
increases in cortical regions usually unrelated to the task. These hyper-activations may be 
related to compensatory mechanisms, but it has been proposed that they are due to an 
exacerbation of dopaminergic tones in the cortex originating from the VTA; because 
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dopamine neurons in the VTA and the substantia nigra degenerate at different rates and at 
different times, activity during motor and cognitive tasks of the cortical regions they project 
to will be related to their integrity and the long-term effects of dopamine replacement 
therapy (Monchi et al., 2010; Macdonald & Monchi, 2011).  
Patients with PD have difficulty with movement initiation (akinesia), which is 
distinguishable from slowness of movement (bradykinesia) (Hallett, 1990). In an H215O 
PET study, Turner et al. (2003) also observed regions normally involved in a task to be 
hypoactive, and different regions normally not involved in the task to be hyperactive. The 
authors used a ‘visuomanual tracking task’ with three increasing velocities to investigate 
bradykinesia in patients with PD. Participants did not perform more temporal errors 
compared with healthy controls, but their movement amplitudes decreased to remain 
synchronized with the moving target. Interestingly, when comparing velocity-related 
activity between PD patients and controls, only the cerebellum showed a decrease in 
activity in PD, suggesting its involvement in bradykinesia. The authors also consider the 
debate that overactivations in PD are related to compensatory mechanisms, and propose that 
instead they may be a correlate of PD pathology (Turner et al., 2003).  
Using SPECT, Rascol et al. (1997) argued for a compensatory role of the 
cerebellum by showing that compared with healthy controls and PD patients on medication, 
patients off medication had an increase in ipsilateral cerebellum and a decrease in the SMA 
activity during a sequential finger-to-thumb opposition task. One could have just as well 
argued, however, that due to the neuronal connections, the pathophysiology of PD generates 
an imbalance that leads to an increase in cerebellar activity [for a review on compensatory 
mechanisms in PD, see (Appel-Cresswell et al., 2010)]. Similarly, Sen et al. (2010) 
described an increase in cortico-cerebellar loop involvement in internally generated 
movements with disease progression that can again be attributed to either compensation or 
pathophysiology. Yu et al. (2007) have also argued for a compensatory role of the cortico-
cerebellar pathway by correlating cortico-striatal and cortico-cerebellar region activity. The 
authors have shown a negative correlation between the contralateral putamen and ipsilateral 
cerebellum in PD patients during a motor timing task, indicating that as the cortico-striatal 
pathway is affected and shows decreases in activity, the cortico-cerebellar pathway 
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compensates by increasing its activity. A shift in this balance, however, could still simply 
be due the pathophysiological imbalance. Palmer et al. (2009a) were driven to similar 
conclusions using a sinusoidal force task of varying frequencies to demonstrate that as 
movement frequency (and therefore difficulty) increases, PD patients first increasingly 
recruit the cortico-striatal and cortico-cerebellar circuits, and then recruit additional areas in 
the bilateral cerebellum and primary motor cortex. In this study, the authors worked with 
the assumption that disease-related activation changes are constant, whereas compensatory 
changes are not. The communication between the two circuits can lead to altered dynamics 
relating to disease pathology, and these dynamics vary through direct synaptic input with 
the level of activity necessary for the task at hand. It is possible, then, that not only 
compensatory regional involvement varies with task difficulty, but the level at which the 
same regions are affected by the disease vary as well.  
Another interpretation of the compensatory role of cerebellar and cortical regions 
comes from a study on movement automaticity. Wu & Hallett (2005) showed that when 
performing automatic movements, patients with PD have increased activity in the 
cerebellum, premotor area, parietal cortex, precuneus and PFC compared with healthy aged 
participants. Although there were no behavioral differences between PD patients and 
healthy controls, patients needed more time to reach automaticity, suggesting that the 
increases in activity are part of compensatory mechanisms. There is however no evidence of 
any correlation of activity in these regions with performance. One could also argue that 
since patients have more difficulty performing the movement sequences automatically, the 
differences in cerebral activity may be due to the pathophysiological changes in PD. In a 
subsequent study, Wu et al. (2011) report a decrease in cortico-striatal and striato-cerebellar 
effective connectivity in PD during SI finger tapping movements, but an increased cortico-
cerebellar connectivity. Once again, as there were no differences in performance between 
PD patients and healthy controls, and no correlation with performance was described, these 
changes in effective connectivity can be due to compensatory mechanisms or 
pathophysiological changes. In contrast, Mattay et al. (2002) showed a significant 
correlation with cortical activity and the number of errors made during a working memory 
task. More specifically, the increases in cortical activity correlated with the number of errors 
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during an n-back working memory task when patients were off medication. In contrast, 
increased activity in the motor regions when patients were on medication correlated with an 
improvement on a motor task (the 0-back version of the working memory task). These 
results are consistent with the motor involvement of the more dopamine depleted nigro-
striatal projections and the cognitive involvement of the less affected mesocortical 
projections. 
One reason why the cerebellum is thought to be involved in compensatory 
mechanisms stems from the observation that patients with PD present difficulty in 
performing SI voluntary movements (Benecke et al., 1987), but perform better when visual 
cues are available (Georgiou et al., 1994). The cerebellum is strongly modulated by visual 
feedback (Debaere et al., 2003), which is thought to be the basis of paradoxical movements 
observed in PD (Glickstein & Stein, 1991). Signals through connections between the visual 
cortex and cerebellum may bypass the cortico-striatal pathway and allow an otherwise 
immobile PD patient to catch a ball being thrown to them or get up and run in the case of a 
fire. In agreement with this theory, a study where patients performed externally cued 
movements in urgent situations showed significant cerebellar involvement in PD patients 
(Ballanger et al., 2008). More specifically, patients were asked to perform SI, externally 
cued (EC) and externally cued-urgent (ECu) arm movements to a contact plate. In the ECu 
condition, participants had to reach to the contact plate fast enough to stop a ball, rolling on 
a ramp, from falling. Ballanger et al. showed that patients performed movements faster in 
the context of a ‘temporally pressing situation’. Furthermore, when comparing the ECu to 
the EC condition, PD patients had greater activity in the cerebellum that correlated with 
movement speed. Based on cerebellar, basal ganglia and thalamic surgeries, there appears to 
be a competitive balance between the cortico-striatal and cortico-cerebellar pathway inputs 
within the thalamus (Stein & Aziz, 1999), the disruption of which would lead to the rigidity 
and tremor observed in PD. Moreover, a recent study has shown that patients presenting 
primarily with tremor have a different brain activity profile than those presenting with 
akinesia and rigidity (Lewis et al., 2011). During internally guided hand movements, 
patients with tremor displayed increases in activity in the cerebellum and thalamus, whereas 
patients with akinesia/rigidity showed increases in the putamen and GP.  
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An imbalance between the affected cortico-striatal pathway and an intact cerebellum 
could mean that the cerebellum becomes recruited in order to compensate for the cortico-
striatal pathway, and therefore display increases in activity. Evidence suggests, however, 
that the cerebellum is not intact in PD (Stevenson et al., 2010). Furthermore, an increase of 
activity does not necessarily mean it is beneficial, and the lack of association between 
increases in activity and improvement in performance in most of the studies mentioned 
above does not support a compensatory role. Although both may be involved, the 
association of the cerebellum with tremor and bradykinesia would rather suggest that such 
activity is related to the pathophysiological changes in PD.  
 
Levodopa treatment 
 
Levodopa is a common choice of treatment for PD, and is used in the hopes of 
restoring activity in the networks through dopamine replacement. Levodopa has been shown 
to decrease the PDRP by suppressing metabolic activity in the putamen, motor cortex and 
cerebellum. In fact, using FDG PET, Feigin et al. (2001) reported that the degree of PDRP 
decline correlated significantly with symptom improvement. The authors also observed a 
significant correlation between UPDRS motor symptom ratings and metabolic decreases in 
the area of the GP and ventral thalamus.  
Although levodopa has no effect on global cerebral blood flow (CBF), it has been 
shown to reestablish activity in the SMA (Buhmann et al., 2003; Jenkins et al., 1992). The 
increases and decreases in activity seen after levodopa administration could be attributed to 
its focusing effects (Ng et al., 2010) of otherwise spatially spread-out activity (Monchi et al., 
2004). It has been suggested that this focusing effect may be due to a dopamine-induced 
increase in signal-to-noise ratio of cellular activity (Winterer, 2006). Moreover, Ng et al. 
(2010) showed that spatial changes in activity patterns could be observed in the contralateral 
motor cortex and ipsilateral cerebellum at low movement frequencies, whereas a change in 
amplitude can only be detected at higher frequency movements.  
Levodopa has been shown to sometimes normalize task-related activity and improve 
performance on motor and cognitive tasks (Mattay et al., 1998; Cools et al., 2002). When 
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patients in the early stages of PD performed volitional movements, levodopa was shown to 
restore the activity of the lateral PMC and SMA, but with no improvement on execution 
times (Haslinger et al., 2001). Although cerebellar changes would also be expected, 
acquisition parameters did not include the cerebellum in the field of view. Others have 
demonstrated a worsening of performance on a motor sequence-learning task as well, which 
correlated with the regional CBF (rCBF) of occipital association areas (Feigin et al., 2003). 
Interestingly, an H2O15 PET study showed an increase in spatial errors of movement that 
correlated with changes in the cerebellum (Feigin et al., 2002), arguing against a 
compensatory role. Using the WCST with patients on and off levodopa in fMRI, we have 
previously shown that levodopa does not restore PFC activity during the WCST (Jubault et 
al., 2009). In accordance with these results, we have recently indicated that even within a 
motor task that solicits both motor and cognitive cortico-striatal regions, levodopa has an 
effect on the motor cortico-striatal circuit, but not the cognitive one (Martinu et al., 2012). 
Although the effect of levodopa on motor symptoms is beneficial, improvement can be seen 
in some tasks whereas performance on others worsens (Gotham et al., 1988; Cooper et al., 
1992).  
Taken together, the effect of levodopa seems to strongly depend on the regions 
implicated in the task at hand, and too much dopamine can be detrimental to processes 
linked to mesocortical pathway and the ventral striatum. For example, tasks that require the 
activity of the dorsal striatum may show improvement after levodopa administration, 
whereas tasks that depend on ventral striatal activity will show a worsening (Monchi et al., 
2010; MacDonald et al., 2011; Macdonald & Monchi, 2011). 
We have recently used an SI and ET task to describe the effect of levodopa on the 
cortico-striatal circuit in patients with PD using fMRI (Martinu et al., 2012). Healthy 
controls and patients at stage I and II of PD were asked to use their right or left hand to 
either press a sequence of buttons following visual cues, button by button (ET task), or 
create a ‘random’ sequence on their own (SI task), with no working memory component. 
Task-related activations were contrasted with a simple single-button repeat control. PD 
patients participated in two scanning sessions, both following overnight withdrawal of 
dopaminergic medication. For one session, patients were asked to take their levodopa one 
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hour before scanning. We observed that healthy controls recruit the putamen at different 
levels for our SI and ET tasks, with the SI task requiring higher activity levels. This effect 
was greatly reduced in patients off medication, and levodopa partially restored the 
putamen’s activity. Results also indicated that cerebellar activity in SI and ET movements 
follows that of the putamen (Figure 18). Activity in the cerebellum of patients with PD was 
also greatly reduced for both SI and ET movements. Most importantly, however, levodopa 
significantly increased the activity in the cerebellum for both types of movements, restoring 
activity at least partially to that observed in healthy controls. We suggest that the activity 
pattern observed is due to the direct connections between the cortico-striatal and cortico-
cerebellar loops, and that levodopa therefore leads to a boost in activity in the striatum as 
well as the cerebellum. Our results with this paradigm further support the notion that the 
pathophysiology of PD affects cerebellum function, and give further support to the 
implication of the cerebellum in the development of LIDs.  
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Figure 18: Activation peaks during ET and SI movements in healthy controls and PD 
patients before and after levodopa 
Location of peaks in the ET versus control (left) and SI versus control (right) for the three 
groups of healthy controls (top), PD patients off medication (middle) and on medication 
(bottom). Anatomical images shown are the average of the T1 acquisitions of all 
participants transformed into stereotaxic space. The functional peaks are shown for t-stat 
values between 3 and 8. Healthy controls have significant activity in cortico-striatal and 
cortico-cerebellar circuits during ET and SI movements. Patients show a decrease in 
cortico-striatal and cortico-cerebellar loop activity before levodopa administration, and an 
increase in cortico-striatal and cortico-cerebellar circuit activity after levodopa 
administration. 
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Dyskinesia 
 
 Levodopa has few short-term side effects (Hauser & Zesiewicz, 2007), but its long-
term administration leads to the development of LIDs in about 50% of patients (Rinne, 
1989; Montastruc et al., 1994). These are mainly manifested by chorea and dystonia at the 
peak of drug dose (Bezard et al., 2001), and are difficult to treat once they appear (Fahn, 
2000). The course of treatment methods and the order of administration for the highest 
benefit and lowest number of side effects were long under debate; keeping a constant 
dopamine intake throughout the length of the disease is difficult (Quinn, 1995; Durif, 1999; 
Khan, 2012). One study reports that over 5 years, 45% of patients in their levodopa group 
developed dyskinesias compared to 20% in the dopamine agonist group (Rascol et al., 
2000). The development of LIDs is associated with a series of changes in genes and proteins 
involved with dopamine receptors as well as non-dopamine transmitters (Bezard et al., 
2001). More specifically, dyskinesias are linked with an imbalance between the direct and 
indirect motor pathways, and in particular with a decrease in GPi activity (Lozano et al., 
2000), although the latter does not account for the symptoms in their entirety. PET studies 
have shown an overactivation of motor regions in dyskinetic patients (Brooks et al., 2000). 
Using 11C-diprenorphine PET, the authors suggest that dyskinesias are mediated by changes 
in opioid receptor binding in the basal ganglia, resulting in the overactivity of fronto-striatal 
projections (Piccini et al., 1997; Brooks et al., 2000). More recently, Nimura et al (2004) 
have shown the implication of sigma-receptors in LIDs. These receptors are localized in the 
substantia nigra, red nucleus and cerebellum (Jansen et al., 1991). Sigma-active neuroleptics 
have been shown to cause dystonic responses in rats after an injection to the red nucleus, 
and their effect on behavior correlated with their affinity with sigma-receptors (Matsumoto 
et al., 1990). Using 11C-nemonapride PET with PD patients presenting with LIDs, Nimura 
et al. (2004) detect sigma-receptor binding potential in the cerebellum; the authors showed a 
correlation of r = 0.893 between receptor binding potential in the cerebellum and LID 
severity score. Moreover, an almost complete disappearance of LID symptoms after pallidal 
surgery coincided with a decrease in receptor binding potential. Although the function of 
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these receptors in LIDs and the reason for their up-regulation after levodopa administration 
is still unclear, these results imply that important changes associated with levodopa 
administration may take place in the cerebellum. 
Repetitive transcranial magnetic stimulation (rTMS) has been suggested as a 
potential treatment for LIDs. Stimulation over the SMA or the primary motor cortex has 
been shown to reduce LIDs transiently (Koch et al., 2005; Brusa et al., 2006). More 
specifically, Koch et al. (2005) showed that 1Hz (inhibitory) rTMS stimulation over the 
SMA reduced dyskinesias, whereas 5Hz (excitatory) rTMS increased them. More recently, 
however, Koch et al. (2009) have attempted theta-burst stimulation (TBS), a sequence that 
can produce changes for over 30 minutes, over the cerebellum of patients with LIDs. A 
single session of inhibitory continuous TBS (cTBS) over the cerebellum was able to reduce 
LIDs (Koch et al., 2009), and one week of cTBS treatment showed considerable symptom 
improvement along with a decrease in cerebellar metabolism as shown by FDG PET (Brusa 
et al., 2012). Taken together, these results suggest that the metabolic and receptor changes 
in PD lead to an imbalance between the cortico-striatal and cortico-cerebellar pathway, and 
underline the importance of the cerebellum’s role in dyskinesias.  
 
Deep brain stimulation 
 
DBS is a very effective form of treatment, mostly used in advanced stages of PD 
when symptoms and medication side effects (e.g. dyskinesia and motor fluctuations) 
become too severe. One main advantage of DBS is that unlike ablation, stimulation is 
reversible and adjustable. The most common targets of DBS in PD are the STN and GPi 
(Volkmann, 2004; Ostergaard & Sunde, 2006; Deuschl et al., 2006; Wider et al., 2008), 
although DBS of the ventral intermediate nucleus of the thalamus seems to be the most 
effective to treat tremor (Lyons & Pahwa, 2008). Stimulations often consist of bilateral 
stimulations of 60-185Hz pulses (Wichmann & DeLong, 2011). STN-DBS in particular 
seems to be effective, helping patients reduce their medication doses and, consequently, 
dyskinesias (Rodriguez-Oroz et al., 2004). The exact mechanisms behind DBS treatment, 
however, are unclear. It appears that the effect of STN stimulation has different effects on 
	  	  	  	  	  
46	  
cell bodies, afferent and efferent axons, modulated by stimulation parameters, leading to 
both complex excitatory and inhibitory effects on the GPi (Wichmann & DeLong, 2011).  
As the treatment effect and regional metabolism changes of STN-DBS are generally 
similar to ablation (Su et al., 2001), one would expect stimulation to have an inhibitory 
effect on the STN, decreasing cortical inhibition. However, according to neuroimaging 
(Hershey et al., 2003; Payoux et al., 2004; Asanuma et al., 2006; Grafton et al., 2006) and 
electrophysiological recordings (Hashimoto et al., 2003), it appears that STN and GPi 
output is in fact increased. The stimulation of the STN was shown to increase rCBF to the 
midbrain, GP and thalamus, but to reduce blood flow to the SMA and PMC (Hershey et al., 
2003). These changes correlated with motor improvement in PD (Karimi et al., 2008). 
Using H215O PET, Payoux et al. (2004) showed that PD patients at rest had significant 
reductions in rCBF in the sensorimotor cortex, PMC, anterior cingulate, SMA and 
cerebellum during high-frequency STN-DBS. When patients performed fist-clenching 
movements in the stimulator-on condition, patients displayed a significant increase in 
activity of the sensorimotor cortex, cingulate cortex and ipsilateral cerebellum. The authors 
report that these activations were in fact due to the reduction of activity at rest, rather than 
an increase in activity during movements. Interestingly, rCBF of the cerebellum off-
stimulator in this study correlated positively with patients’ akinesia (Payoux et al., 2004). 
Additional PET studies also found rCBF increases in the STN and lentiform nucleus, and 
rCBF decreases in the thalamus and cerebellum at rest during STN stimulation (Hilker et al., 
2004; Geday et al., 2009). Furthermore, DBS appears to cause task-specific adaptation 
changes in brain activity, possibly via decreases in pathologic network activity (Grafton et 
al., 2006). Indeed, STN-DBS, just like levodopa, has been shown to reduce PDRP, 
inherently reducing cerebellar overactivity (Trost et al., 2006; Asanuma et al., 2006), 
suggesting that STN-DBS leads to symptom improvement through the alteration of network 
communication within and between the cortico-cerebellar and cortico-striatal pathways.  
 
Concluding remarks 
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In this review, we have shown the important implication of both the cortico-striatal 
and cortico-cerebellar pathways in PD, and the changes related to levodopa administration 
and DBS. Direct evidence that the patterns of activity of the cerebellum and the cortico-
cerebellar loop are truly compensatory is still lacking, and traditional neuroimaging studies 
showing increases or decreases in activity always depend on interpretation. It has been 
suggested that externally cued movements are mainly processed by the cortico-cerebellar 
loop and remain intact for the most part, whereas internally cued movements are processed 
through the dysfunctional cortico-striatal loop (Lewis et al., 2007).  
Based on the results reviewed, we propose that the cortico-cerebellar pathway 
activity in PD does not remain intact, as is often suggested, but that it is also affected by the 
disease, and related to some of the observed symptoms. In other words, the cortico-striatal 
and cortico-cerebellar circuits are very closely related through direct interactions as well as 
cortical associations, and the changes in PD affecting the cortico-striatal circuits will 
therefore also affect the cortico-cerebellar pathway. Changes in cerebellar activity should 
consistently correlate with improvements in performance in order to show clear 
compensatory involvements. The opposite seems to have been shown so far (Feigin et al., 
2002). Although both compensatory and pathophysiological changes are most likely present 
in PD, the interpretation of neuroimaging studies as supporting one or the other must be 
done with care.  
An increase in cerebellar activity after levodopa administration can be due to 
different reasons, such as by a direct effect of dopamine on cerebellar receptors, or 
indirectly though the connections between the cortico-cerebellar and cortico-striatal 
pathways, as previously suggested by Stevenson et al. (2011). Additional research will be 
necessary to establish the effect of levodopa on the cerebellum. 
It has been suggested that oxidative stress and mitochondrial dysfunction plays an 
important role in the cell degeneration in PD (Jenner, 2003). A recent PET study has 
demonstrated an enhancement of oxidative stress in PD patients that increased with disease 
progression, suggesting that neurodegeneration in PD is associated with oxidative stress 
(Ikawa et al., 2011). Paradoxically, levodopa has pro-oxidant properties that promote free 
radical formation, and lead to cell death in cellular models of PD (Martignoni et al., 1999; 
	  	  	  	  	  
48	  
Sabens et al., 2010), explaining the growing number of side effects with long-term 
administration. The increase in activity after levodopa administration seems to be 
detrimental in the long run, leading to symptoms such as dyskinesia. Indeed, one major 
confound in most PD studies (including our own) is that one cannot completely distinguish 
between the pathophysiology of the disease and the accumulated effect of dopaminergic 
medication. It may be useful in the future to study cerebellum function via neuroimaging in 
non-medicated de novo PD patients. 
It is interesting to note that the cortico-cerebellar pathway has been shown to be strongly 
involved in dystonia, also originally considered a disorder of the basal ganglia (Niethammer 
et al., 2011), and the cerebellum may not necessarily be involved in compensatory 
mechanisms (Sadnicka et al., 2012). Inversely, several types of spinocerebellar ataxias, 
primarily disorders of the cerebellum, have also been shown to lead to considerable basal 
ganglia degeneration (Seidel et al., 2012). 
The limitations of neuroimaging make the distinction between compensatory 
mechanisms and disease pathophysiology difficult. TMS may prove to be a useful tool in 
the study of living PD patients. We propose a few ways in which the compensatory 
mechanisms may be separated from the pathophysiological changes in PD. By using tasks 
of sequence learning and motor adaptation, one can separate, for the most part, activity 
between the cortico-striatal and cortico-cerebellar loops. As mentioned above, when 
participants reach the final stages of learning, sequence learning tasks are mainly operated 
by the cortico-striatal loop, whereas motor adaptation tasks by the cortico-cerebellar loop. 
Following inhibitory TBS over the cerebellum, both PD patients and healthy controls 
should show a decrease in performance on the adaptation task. On the other hand, if 
cerebellar activity in PD compensates for cortico-striatal loop dysfunction, patients with PD 
should show a decrease in performance on sequence learning tasks, and there should be no 
effect on performance of healthy controls. In contrast, if cerebellar activity is related to 
pathophysiology, performance of PD patients on sequence learning tasks should be 
improved. A similar protocol in a task that recruits the cerebellum or basal ganglia 
selectively, such as the SI and ET model suggested by Lewis et al. (2007) should lead to 
similar conclusions. More specifically, their task consists of SI movements associated with 
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cortico-striatal loop activity, whereas the ET movements are associated with cortico-
cerebellar loop activity. Inhibitory cerebellar TBS in PD patients should decrease 
performance of SI movements if cerebellar activity is compensatory. 
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Chapter 3: Striatal activity and cortical hyper-activity in PD 
 
 The next chapter of this thesis is an article published in European Journal of 
Neuroscience in 2012. Although it follows the preceding article, these were the first 
analyses performed, and the conclusions drawn from them have been described and used in 
support of the pathophysiology hypothesis we suggested in the previous section.  
Prior to the acquisitions of data for this protocol, our laboratory’s results had 
suggested that levodopa increased motor cortico-striatal loop activity during the WCST, but 
not cognitive cortico-striatal loop activity (Jubaut et al., 2009). The primary focus of this 
chapter was to extend these findings to a motor task, namely the SI and ET finger 
movement task used in our previous protocol (Francois-Brosseau et al., 2009; see appendix). 
In contrast to the WCST project, we wanted to compare the cerebral patterns of patients 
with PD with a group of healthy participants. Our major findings here are that the hyper-
activations observed in patients with PD that are unrelated to the task, as described in 
chapters 1 and 2, are not normalized by levodopa. More specifically, healthy participants 
showed increases in activity at the junction of the ventrolateral prefrontal cortex (VLPFC) 
and the insula when comparing SI to ET movements, but not when comparing ET 
movements to the control condition. On the other hand, patients with PD had the opposite 
pattern (i.e. increased activity in this region in ET vs. control, but not SI vs. ET). Instead of 
restoring this discrepancy, levodopa has no effect; in this chapter we suggest that these 
hyper-activations are associated with the pathophysiology of PD, and that they may even be 
related to the prolonged use of dopaminergic medication. 
The second goal of this study was to examine the response of the putamen and other 
regions involved in the motor cortico-striatal circuit to SI and ET movements. In healthy 
young adults, we had demonstrated that the putamen is increasingly recruited for control, 
ET, then SI movements. In this study, we show that in patients with PD the differences in 
activity between these three types of movements are greatly reduced, and levodopa partially 
restores these differences to those observed in healthy participants. We suggest that 
levodopa has an equivalent effect on regions of the motor cortico-striatal circuit for both SI 
and ET movements (i.e. a non-task specific effect). 
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Abstract: 
 
 Motor studies of PD have shown cortical hypo-activity in relation to nigrostriatal 
dopamine depletion. Cognitive studies also identified increased cortical activity in PD. We 
have previously suggested that hypo-/hyper-activity patterns observed in PD are related to 
striatal contribution. Tasks that recruit the striatum in control participants are associated 
with cortical hypo-activity in PD patients, whereas tasks that do not result in cortical hyper-
activity. The putamen, a structure affected by neuro-degeneration observed in PD, shows 
increased activation for ET and SI movements. The first goal of this study was to evaluate 
the effect of levodopa on the putamen's response to ET and SI movements. Our second goal 
was to assess the effect of levodopa on hypo/hyperactivity patterns in cortical areas. Both 
PD patients on and off levodopa and healthy volunteers performed SI, ET and control finger 
movements during fMRI. Healthy participants displayed significant differences in putamen 
activity in ET and SI movements. These differences were reduced in patients off medication, 
with non-task specific increases in activity after levodopa administration. Furthermore, the 
VLPFC showed significant increases in activity during SI movements in healthy controls, 
while it was hypo-active in PD. This region showed significantly increased activity during 
ET movements in patients off medication. Levodopa had no effect on this discrepancy. Our 
results suggest that dopamine replacement therapy has a non-task specific effect on motor 
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cortico-striatal regions, and support the hypothesis that cortical activity increases and 
decreases in PD are related to mesocortical dopamine pathway imbalance. 
 
Introduction: 
 
 The substantia nigra, thalamus, basal ganglia and cortex are a part of motor and 
cognitive ganglia-thalamocortical loops originally described by Alexander et al., (1986). 
Using the WCST, we previously reported that the caudate nucleus and VLPFC (cognitive 
loop) were involved in set-shifting, and the putamen and PMC (motor loop) in shift 
execution (Monchi et al., 2001; Monchi et al., 2006). 
 Early motor neuroimaging studies in patients with PD showed a decrease in 
premotor and motor cortical activity (Playford et al., 1992). Decreases in cortical activity 
were thought to stem from nigrostriatal dopamine depletion (Albin et al., 1989). More 
recent cognitive neuroimaging studies, however, identified cases of increased cortical 
activity (Cools et al., 2002). Our previous work suggested that cortical activity modulation 
observed in PD patients depends on striatal involvement (Monchi et al., 2004; Monchi et al., 
2007). More specifically, we suggest that for tasks that require the striatum (e.g., shifting 
attention), PD patients exhibit decreased activity in prefrontal regions compared to control 
participants (hypo-activation). In contrast, when performing tasks that do not require the 
striatum (e.g., task execution without shifting attention) in healthy controls, PD patients 
show significant prefrontal and parietal increases in activity (hyper-activation) (Monchi et 
al., 2007). Mesocortical dopamine disruption may prevent cortical functioning and lead to 
these abnormal increases in activity (Monchi et al., 2010).  
 Levodopa has considerably beneficial effects on PD motor symptoms, and therefore 
remains one of the most commonly used medications. We have recently looked at the effect 
of levodopa on patterns of cerebral activity in PD patients while performing the WCST 
(Jubault et al., 2009). After drug administration, patients showed an increase in regions that 
are a part of the motor loop, while regions that are a part of the cognitive loop remained 
unaffected. These results are consistent with the observation that dopaminergic medication 
has a much stronger effect on motor rather than cognitive symptoms.  
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 Greater involvement of the putamen in SI compared to ET movements has been 
observed in healthy controls (Cunnington et al., 2002). In a previous study, we reported 
increased activity in the putamen when comparing control (CTL), ET and SI finger 
movements (Francois-Brosseau et al., 2009). In healthy individuals, activity in the putamen 
increased depending on movement type. ET movements recruited higher levels of activity 
than control movements, and SI movements were associated with even higher levels of 
activity in the putamen. Furthermore, ET movements recruited the putamen and the PMC, 
while SI movements additionally involved the caudate nucleus and DLPFC. 
 Our first goal was to investigate the response of the putamen to different types of 
movements in PD, and the effects of dopaminergic medication. We hypothesized that 
differences in putamen activity between tasks would be reduced in PD patients off 
medication, but that medication would help re-establish the putamen's involvement. The 
second aim was to assess effects of levodopa on the hypo/hyperactivity pattern of cortical 
regions previously observed in PD patients. Striatum-related cortical hypo-activity observed 
in PD could be a result of nigrostriatal degeneration. Cortical hyper-activity, however, could 
either be a form of compensation and/or mesocortical imbalance. We propose that cortical 
hyperactivity in PD patients is primarily due to mesocortical dopamine pathway disruption 
(Monchi et al., 2007; Monchi et al., 2010; Macdonald & Monchi, 2011). We consequently 
do not expect cortical activity to correlate with performance on the task, and medication 
intended to optimize dopamine levels in the dorsal striatum to have no significant effect on 
this pattern of activity.   
 
Methods 
 
Participants 
 
All participants gave informed consent. This project was approved by the Joint Ethics 
Committee of the Regroupement Neuroimagerie Quebec (RNQ), which follows the 
guidelines of the Tri-Council Policy Statement of Canada, the civil code of Quebec, the 
Declaration of Helsinki and the code of Nuremberg. 
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Patients. 12 right-handed patients diagnosed with PD [mean age 62.89±6.70 (SD), 6 women 
and 6 men] participated in the study. All PD participants met the core assessment program 
for surgical interventional therapy criteria for the diagnosis of idiopathic PD (Langston et 
al., 1992; Defer et al., 1999). All patients also met the UK brain bank criteria for the 
diagnosis of PD (Hughes et al., 1992). Motor disability of individuals within the PD group 
was in the mild to moderate severity range according to the Hoehn and Yahr staging criteria 
(Hoehn & Yahr, 1967). Handedness was assessed with the Edinburgh Handedness 
Inventory (mean average 91.57±14.47), all individuals were screened for early signs of 
dementia prior to the experiment using the Montreal Cognitive Assessment (MoCA) 
(Nasreddine et al., 2005) (mean average ON 26.92±1.88, OFF 27.55±1.51), the presence 
and severity of depression in all PD participants was estimated using the Beck Depression 
Inventory II (BDI-II) (mean average 12.58±11.74), and at each session, the motor 
symptoms of all PD patients were measured with the UPDRS-III (OFF 31.17±4.87 and ON 
23.42±6.95). In addition to levodopa, most patients were also taking other antiparkinsonian 
drugs such as COMT inhibitors (n=5), MAO-B inhibitors (n=6), dopamine agonists (n=3) 
and others (n=3). Detailed patients’ demographic and clinical scores are given in Table Ia.  
 
Healthy controls. 14 right-handed healthy controls [mean age 61.74±6.62, 6 males and 8 
females] were also recruited. All controls completed the MoCA (mean average 27.79±1.89), 
the BDI-II (mean average 4.21±4.34) and the Edinburgh Handedness Inventory (mean 
average 84.85±13.15). Detailed demographic and scores are given in Table Ib. 
 
Procedure 
 
Each PD patient came for two scanning sessions, at least one week apart. For each session 
they were asked to withdraw from all their antiparkinsonian medications for at least 12 
hours prior to the appointment. All patients stayed off all medications for their OFF session, 
and took only their usual levodopa 1 hour before the scanning hour for the ON session. ON 
and OFF sessions were counterbalanced across patients. Healthy controls (HC) came for 
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one scanning session only, and performed the same tests as patients except for the UPDRS. 
All participants practiced three blocks (for a total of 9 times per condition) of the task to 
ensure they could perform adequately in the scanner. 
 
Behavioral tasks 
 
Using the right hand, participants performed a SI random movement condition, an ET 
follow condition, and a single-button repeat condition (control). Five blue squares were 
displayed, each square corresponding to a button on the response box; all fingers were used 
except for the pinky, as it was considered difficult for patients. The blue square representing 
the pinky was present nonetheless as a reference for finger positioning. The task included a 
total of twenty button presses per condition. Instructions were given for 2.5 seconds before 
the five blue squares appeared to indicate which task should be performed. 
 
Control task. During the control task, one colored square switched from blue to green, 
indicating that the corresponding button must be pressed. For the duration of every button-
press, the square would turn yellow to show the subject’s response, and then turn green 
again to illustrate that it was ready to be pressed again. This continued until the subject 
successfully completed all button-presses. The button to be pressed during the control task 
was randomly selected by the computer, and remained the same for the duration of the 
condition.  
 
ET task. During the ET follow task, the button to be pressed varied at random each time. 
The subject had to follow the sequence as the blue squares alternately turned green. Every 
button-press resulted in the corresponding square turning yellow if it was correctly pressed, 
or red if an error was made (i.e., an incorrect selection). The computer program was 
designed to avoid repetitive sequences and patterns or selecting the same button twice in a 
row. 
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SI task. For the SI random condition, all four squares would turn green, and the subject had 
to choose his/her own sequence. Once again, the buttons pressed made the green squares 
turn yellow, after which the next button was ready to be selected. For this particular task we 
asked the participants to switch buttons continuously. The same button being pressed twice 
in a row was considered an error, and the equivalent square would turn red. We also asked 
that participants refrain from automatic and repeated sequences such as 1-2-3-4 or 4-3-2-1.  
 
fMRI 
 
Data acquisition. Participants were scanned using the 3T Siemens TIM MRI at the 
Functional Neuroimaging Unit (UNF) of the Centre de Recherche de l’Institut Universitaire 
de Gériatrie de Montréal (CRIUGM). Each scanning session comprised a T1-weighted 
three-dimensional volume acquisition (voxel size 1mm3) for anatomical localization, 
followed by four T2*-weighted functional echoplanar acquisitions with BOLD contrast. 
Each run consisted of 146 frames of 43 slices (matrix size 128x128, voxel size 2.34 x 2.34 x 
3mm) acquired at a repetition time of 3.5 seconds. 
 
Data analysis. Data analysis was performed using fmristat software (Worsley et al., 2002). 
For a detailed depiction, see François-Brosseau et al., (2009). Briefly, each run was first 
realigned to the fourth frame for motion correction and smoothed using a 6 mm full width 
half-maximum (FWHM) isotropic Gaussian kernel. The statistical analysis of the fMRI data 
was based on a linear model with correlated errors. Effect and standard effect files were 
spatially normalized by linear transformation into the Montreal Neurological Institute 
(MNI) standard proportional stereotaxic space, based on that of Talairach and Tournoux 
(Talairach & Tournoux, 1988), using the algorithm of Collins et al. and the ICBM152 atlas 
as an approximation (Collins et al., 1994). Anatomical images were also normalized to the 
same space. Runs, sessions and subjects were combined using a mixed effects linear model. 
For each group (HC, OFF and ON), the average BOLD signal obtained during the SI and 
ET movement conditions were compared with those of the control condition. Additionally, 
the SI condition was compared with the ET condition, for a total of three contrasts per 
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group. We also performed inter-group comparisons (HC vs. ON, HC vs. OFF and ON vs. 
OFF) for each one of these three contrasts (SI vs. CTL, ET vs. CTL and SI vs. ET). 
 Significant peaks are reported using the minimum p value of the single peak and 
cluster analysis. All peaks (minimum 10mm cortical inter-peak distance and excluding 
cerebellar regions) that reached p<0.05 corrected are reported. Predicted peaks (present in 
Francois-Brosseau et al., 2009) that reached p<0.0001 uncorrected are also reported, and 
indicated by an asterisk in result tables. 
 
Results 
 
Clinical scores: 
 
There were no significant differences between PD and HC in age or handedness. Patients 
ON had significantly lower UPDRS scores than OFF (p=0.005). PD patients had 
significantly higher BDI-II scores (p=0.023) and lower MoCA scores (p=0.048) than HC, 
but there were no significant correlations between MoCA or BDI-II scores and their 
behavioral performance during our finger-movement task. There was no significant effect of 
session order on MoCA scores. 
 
Behavioral performance during scanning: 
 
Reaction times. For our SI, ET and CTL, healthy controls' performance was as follows: SI 
mean average 748±203ms, ET mean average 1001±153ms, and CTL mean average 
818±48ms. Parkinson's patients performance was as follows: SI mean average OFF 
842±168ms and ON 870±150ms, ET mean average OFF 1106±303ms and ON 1149±171ms, 
and CTL mean average OFF 717±119ms and ON 746±169ms. PD patients had significantly 
slower  reaction times than HC in the ET condition (p=0.041).  
 
Errors. The percentage of errors was calculated by (number of errors) / (total button 
presses) for each condition. For our SI, ET and CTL tasks, healthy controls' error 
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percentages were: SI: 1.03%, ET: 2.85% and CTL: 0.27%. Parkinson's patients error 
percentages were: SI: OFF 2.87% and ON 2.55%, ET: OFF 8.92% and ON 10.96%, CTL: 
OFF 0.76% and ON 1.48%. PD patients in the ON condition made significantly more errors 
than HC in the ET condition (p=0.005). 
 
fMRI results: 
 
In the healthy control participants, significant differences in activity were observed in the 
caudate nucleus, the putamen and the PFC during the SI condition, and the PMC in ET and 
SI tasks. Significant differences in activity in the putamen were observed in all three 
contrasts (SI vs. CTL, SI vs. ET and ET vs. CTL), showing increasing involvement of the 
structure in CTL, ET and SI movements (Figure 19). PD patients off medication displayed 
significant putamen activity for the SI vs. CTL contrast only, with a trend in the ET vs. CTL 
contrast. After levodopa administration, significant putamen activation was observed in SI 
vs. CTL and ET vs. CTL. In PD patients, the administration of dopaminergic medication 
was associated with a significant difference in activity in the PMC but not in the caudate 
nucleus or the DLPFC. Interestingly, we also observed significant differences in activity in 
the VLPFC at the junction of the insula in patients off medication during ET movements. 
The VLPFC was not recruited for ET movements in healthy controls, and levodopa did not 
normalize this activity.  
 
1. ET versus control (Table II): 
 
Healthy controls. The comparison of the ET and CTL tasks in HC showed a significant 
increase in activity in the bilateral PMC (area 6), PPC (areas 7 and 40), and the occipital 
cortex (areas 17, 18, 19 and 37). Significant activation was also observed in the right SMA 
(area 6) and the left sensory cortex (area 3). Subcortical activations included the bilateral 
putamen. 
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OFF session. Patients off medication presented significantly increased bilateral activity in 
the PMC (area 6), SMA (area 6), PPC (areas 7 and 40), and occipital cortex (areas 17, 18 
and 19). Significant activation was also observed in the left VLPFC at the junction of the 
insula (junction of areas 47/12 and 13) and the left somatosensory cortex (area 3). 
Subcortical activations included the bilateral putamen. 
 
ON session. Patients on medication revealed significant activations bilaterally in the VLPFC 
/ insula (area 47/12 - 13), the PMC (area 6), SMA (area 6), PPC (areas 7 and 40) and 
occipital cortex (areas 17, 18, 19 and 37), as well as in the right somatosensory cortex (area 
3). Subcortical activations included the bilateral putamen and thalamus. 
 
2. SI versus control (Table III): 
 
Healthy controls. When comparing the SI and CTL conditions, HC displayed significant 
activations bilaterally in the VLPFC / insula (area 47/12 - 13), PMC (area 6), SMA (area 6), 
PPC (areas 7 and 40) and visual cortex (areas 17, 18, 19, 31 and 37). HC also displayed a 
significant increase in activation in the left anterior PFC (area 10), sensory cortex (areas 2 
and 3) and the right DLPFC (area 8,9). Subcortical activations were observed bilaterally in 
the putamen and thalamus.  
 
OFF session. In the SI minus CTL comparison, patients off medication had significant 
bilateral activations in the DLPFC (area 9 - 9,46), VLPFC / insula (area 47/12 - 13), PMC 
(area 6), SMA (area 6), PPC (areas 7 and 40). Significant activation was also observed in 
the left motor cortex (area 4), as well as the right visual cortex (area 19). Subcortical 
activations were observed in the putamen bilaterally and the left thalamus. 
 
ON session. Patients ON medication displayed significant increases in activity in the 
bilateral DLPFC (area 9 - 9,46), VLPFC / insula (area 47/12 - 13), PMC (area 6), SMA 
(area 6), and PPC (areas 7 and 40). They also showed significant activations in the left 
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motor (area 4) and sensory (area 2) cortex, and the right visual cortex (area 19). Significant 
subcortical activations were observed bilaterally in putamen and thalamus.  
 
3. SI versus ET (Table IV): 
 
Healthy controls. In the contrast of SI versus ET, HC showed a significant increase in 
activity bilaterally in the anterior PFC (area 46/10), mid-DLPFC (area 9 - 9,46 and 46), 
VLPFC / insula (area 47/12 - 13), PMC (area 6), pre-SMA (area 6,8) and PPC (areas 7 and 
40). Other significant activations were also observed in the left posterior PFC (pPFC) (area 
6,44), the right sensory cortex (area 2), and left SMA (area 6). Subcortical significant 
activations included the caudate and putamen bilaterally, and the left thalamus. 
 
OFF session. Patients OFF medication displayed significant increases in activity in the left 
DLPFC (area 9 - 9,46) and the left PPC (area 40). No subcortical activation was observed. 
 
ON session. Patients ON medication showed significant increases in activity in the bilateral 
PMC (area 6), the right DLPFC (area 9 - 9,46) and PPC (area 7), as well as the left sensory 
cortex (area 3), SMA (area 6) and superior parietal lobule (area 5). No significant 
subcortical activity was observed. 
 
4. Between-group comparisons: 
 
All statistically significant inter-group differences between HC, ON and OFF for SI vs. 
CTL, ET vs. CTL and SI vs. ET are reported in Table V. 
 
Discussion: 
 
 Our first major goal was to explore the patterns of brain activity in PD patients 
during the performance of control, ET and SI movements that increasingly solicit the 
putamen. As hypothesized, the putamen's response to these movements is reduced in PD 
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patients as compared with control participants. The second goal of this study was to 
understand the effect of levodopa on the striatum-dependent cortical hypo- and hyper-
activity patterns often observed in PD patients in fMRI (Monchi et al., 2007). Using a finger 
movement task, we hypothesized that patients would display prefrontal hyper-activations 
not normally activated in control participants in the same task, and that levodopa would 
have no significant effect. Consistent with our hypotheses, we observed a significant 
increase of activity in the depth of the horizontal ramus of the Sylvian fissure (at the 
intersection between the VLPFC and insula) in patients while they performed the ET task. 
In contrast, this region's activity was significantly increased in the SI task in healthy 
controls. Levodopa administration did not have a significant effect on this discrepancy.  
 
Healthy participants 
 In accordance with our previous study on young adults (François-Brosseau et al., 
2009), control participants displayed increased putamen activity for the two tasks compared 
with control movements (Figure 19). Furthermore, healthy controls significantly recruited 
regions involved in the cognitive and motor ganglio-thalamocortical loops described by 
Alexander et al. (1986). More specifically, there was an increase in activity in structures that 
make up the motor loop (putamen and PMC) in ET movements. Additionally, there was an 
increase in activity in regions associated with two cognitive loops (caudate / DLPFC and 
caudate / VLPFC) when comparing SI to ET movements. In agreement with previous 
studies, these results support the hypothesis that SI movements require larger basal ganglia 
and prefrontal input than ET movements (Gordon et al., 1998; Jenkins et al., 2000; 
Cunnington et al., 2002; Elsinger et al., 2006). Moreover, the parietal cortex is significantly 
more active during both SI and ET conditions, which is consistent with its purported role in 
visual cue-based representation of movements and spatial attention (Deiber et al., 1996; 
Harrington et al., 2000). 
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Figure 19: Diagram of putamen activity during control, ET and SI movements in HC, 
ON and OFF 
Units are arbitrary and hold a symbolic relationship between groups. Solid lines indicate 
significant statistical difference in putamen activity between conditions, dotted lines 
indicate sub-threshold peaks. Healthy participants show sub-threshold putamen activity in 
ET movements but significant activity in SI and SI vs. ET movements. Patients off 
medication display sub-threshold putamen activity in ET movements and significant 
putamen activity in SI movements. Finally, after levodopa administration, patients show 
significant putamen activity in both ET and SI movements. 
 
 
PD patients - Motor loop: 
 During SI movements, a significant increase in activity was observed in the motor 
loop (putamen and PMC) in both healthy controls and PD patients (Figure 20). There was a 
statistical trend in those regions for ET movements in controls or patients OFF, and a 
significant increase in patients ON. Levodopa does not seem to affect SI or ET movement-
related activity differently, indicating that its effect on the putamen does not depend on the 
type of movement.  
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Figure 20: Location of peaks in the ET versus control (left) and SI versus control 
(right) for the three groups of participants 
Anatomical images shown are the average of the T1 acquisitions of all participants 
transformed into stereotaxic space. The functional peaks are shown for t-stat values 
between 3 and 6. Healthy controls (top row) show sub-threshold putamen activity in ET 
movements (left), and significant bilateral putamen in SI movements (right). Patients off 
medication (middle row) display sub-threshold bilateral putamen activity in ET movements 
(left), and significant bilateral putamen in SI movements. Patients on medication (bottom 
row) have significant left putamen in ET movements (left), and significant bilateral putamen 
in SI movements (right). Healthy controls, patients on and off medication have significant 
PMC activity in SI and ET movements. 
 
 Lewis et al. investigated SI and ET movements in a pair of twins discordant for PD. 
Movement-related activity was significantly increased in the basal ganglia-cortical circuitry 
after levodopa administration for SI movements, and a trend for ET movements in the 
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affected twin (Lewis et al., 2007). Further studies showed that while PD patients can reach 
movement automaticity, the level of cortical activity observed is greater. This may be 
necessary to compensate for basal ganglia dysfunction (Wu & Hallett, 2005). Furthermore, 
PD patients require higher brain activity levels to perform movements of different speeds, 
compared with healthy controls (Palmer et al., 2009a). Boecker et al. (2008) studied the role 
of the basal ganglia in the planning of motor sequences. Their results showed that the 
putamen was involved in the planning of SI movements, whereas the substantia nigra was 
involved in both internally and externally generated movements (Boecker et al., 2008). 
They did not however observe increased activation in the putamen. This may have been due 
to pre-training, leading to increased automaticity of the sequence. Increased activity in the 
putamen was observed in our protocol likely because finger movement sequences were 
randomly generated, and therefore unpredictable.  
 Similar to the healthy volunteers, the putamen was activated for ET and more so for 
SI movements compared to the control condition in patients before and after levodopa 
administration (Figure 19). The degree to which the putamen was recruited differed 
depending on the group of participants. In healthy controls, there was a statistical trend 
between the ET and CTL condition, and significant bilateral increases in activity between 
the SI and ET conditions. Consistent with previous studies, these results support the role of 
the putamen in the planning and self-generation of movements (Helmich et al., 2006; 
Boecker et al., 2008). PD patients off medication displayed sub-threshold putamen activity 
increases between the ET and CTL conditions, and significant bilateral increases between 
the SI and CTL tasks. There was no significant difference in the putamen between the SI 
and ET conditions.  
 Levodopa administration globally increased activity in the motor loop. The 
difference between SI and CTL tasks was significant in patients on medication. There was 
also a significant difference between ET and CTL tasks (Figure 20). While no significant 
differences in the motor loop were detected for comparisons between groups of patients on 
and off medication (Table V), the PMC and SMA were more active after levodopa 
administration based on within-group comparisons (Table IV). There were no statistical 
differences in task performance before or after drug administration, and BOLD activity did 
	  	  	  	  	  
65	  
not correlate significantly with performance in any of the tasks (results not shown). We can 
suggest, then, that levodopa increases motor loop activity in general rather than modulating 
it by movement type.  
 
PD patients - Cognitive loop: 
 The cognitive loops formed by the caudate nucleus and the DLPFC and VLPFC 
were involved in SI movements in healthy controls compared with the ET condition (Figure 
21). In PD patients, regions that make up the cognitive loop show no significant activity 
before or after levodopa administration. This is consistent with our previous study where 
levodopa did not change activity in cognitive loop structures (caudate nucleus, DLPFC, 
VLPFC) normally observed in the performance of the WCST (Jubault et al., 2009). Because 
the latter study did not involve healthy controls, however, we couldn't distinguish healthy 
and parkinsonian activity patterns. 
 
Figure 21: Location of peaks associated with the cognitive portion of SI movements 
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The functional peaks are shown for t-stat values between 3 and 6. Healthy controls (top) 
show significant activity in the VLPFC (left) and the DLPFC. No significant differences are 
observed in patients off medication (middle), and there is no effect of levodopa (bottom). 
 
 The results of our current study implicate the VLPFC / insula. This region is paired 
with the caudate nucleus when it is involved in SI movements in healthy controls. In PD 
patients, however, there was an over-activation of the VLPFC / insula in the ET condition 
(Figure 22), a condition that does not normally recruit the caudate nucleus. Consistent with 
previous research, we observed hyper-activation of the PFC in PD patients off medication 
for tasks that do not normally activate the striatum in healthy participants, and a hypo-
activity of these regions in tasks that do (Monchi et al., 2004; Monchi et al., 2007; Monchi 
et al., 2010). Importantly, in the present study, levodopa did not normalize this effect. This 
is in agreement with the hypothesis that medication leads to a dopamine overload in the 
mesocortical pathway at the early stage of the disease leading to over-activation of 
prefrontal regions that are not solicited with dorsal striatum in healthy individuals for the 
task (Macdonald & Monchi, 2011). This result also supports the idea that the hyper- and 
hypo-activity effect is linked to dopaminergic medication administration. However, it seems 
unlikely that it is performance-dependent, as there is no difference in task performance 
between the three groups of participants, and no areas correlated with task performance in 
any of our three conditions (results not shown). 
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Figure 22: Peaks at the intersection of the VLPFC and the insula in healthy controls 
and patients 
The functional peaks are shown for t-stat values between 3 and 6. Healthy controls (top) 
show VLPFC / insula activity in SI movements (left) but not in ET movements (right), 
whereas patients off medication show VLPFC / insula activity in ET (right) but not SI (left) 
movements. Medication has no significant effect on this discrepancy (bottom). 
 
 In a study comparing PD patients on and off levodopa performing the Tower of 
London, Cools et al. (2002) observed a task-specific decrease in the DLPFC and a task-
specific increase in the occipital lobe after levodopa administration. Medication restored 
DLPFC activity to normal. Another study looking at the effect of levodopa on volitional 
movements observed decreased activity in premotor and parietal regions after levodopa 
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administration (Haslinger et al., 2001). In the present study, we observed a global decrease 
in prefrontal activity in PD patients compared with healthy controls (Table V). The 
difference between the VLPFC / insula activity observed in our study and the prefrontal 
activity decreases observed in SI vs. ET in Cools et al. (2002) is that the VLPFC / insula 
activity is not task-related (i.e., it is not activated for the condition at hand in control 
participants). Dopamine has been shown to improve corticostriatal connectivity, thereby 
affecting performance efficiency (Nagano-Saito et al., 2008). Moreover, levodopa may 
partially restore task-related activity, as we saw previously with the motor loop, but may not 
affect, or may be detrimental instead, to non-task-related processes. The recruitment of 
novel areas may either be interpreted as compensation (Palmer et al., 2009a), or as an 
indicator of neurological dysfunction (Dagher & Nagano-Saito, 2007) of the mesocortical 
pathway. Our results support the idea that increases in prefrontal regions that are unrelated 
to the task are not due to a compensatory mechanism, but are rather related to an imbalance 
of dopamine in the mesocortical pathway.  
 Other studies have reported different effects of levodopa on performance (Gotham et 
al., 1988). Some demonstrate changes in cortical activity after levodopa administration 
linked with improvement (Cools et al., 2002; Fera et al., 2007), others with deterioration of 
task accuracy (Swainson et al., 2000; Mattay et al., 2002) (for review, see Macdonald & 
Monchi, 2011). Perhaps due to practice sessions prior to scanning, task performance did not 
change before or after levodopa administration in our protocol. Other authors report 
differences in striatal and frontal region activity depending on cognitive impairment in 
patients (Lewis et al., 2003). There was also no difference in cognitive performance 
between our PD patients and our healthy controls. It is unlikely that these changes in 
cortical activity were attributed to differences in depression (BDI-II) or cognitive 
performance (MoCA) between patients and controls since neither test correlated with 
performance.  
 
Conclusion: 
 We have shown the modulation of the putamen by three types of movements. The 
putamen was increasingly implicated in control, ET and SI finger movements. These 
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differences in activity were reduced in patients affected by PD. Levodopa partially restored 
this pattern by a general increase in activity irrespective of the task being performed. While 
levodopa affected the putamen and pre-motor regions involved in SI and ET tasks, no effect 
was observed in the caudate nucleus and DLPFC involved in the cognitive components of 
the task. In line with an imbalance of mesocortical dopamine tone, levodopa appears to play 
no significant role in the striatum-related hyper-activity patterns of cortical regions in PD. 
In conclusion, our results suggest that dopamine replacement therapy has a beneficial effect 
on motor cortico-striatal regions, but no significant effect on task-related cognitive cortico-
striatal regions, and no significant regulation of cortical hyper-activations in cognitive 
regions not usually required for the task. Further research comparing medicated and non-
medicated patients will be necessary to fully understand the interaction between medication 
and cortical activity variations at different stages of the disease. 
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Table I - Demographics of patients (A) and healthy controls (B) 
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Abbreviations: Sub: subject, G.: gender, Dur.: duration of illness in years from onset, Other 
Meds: patients’ medications (1 = levodopa; 2 = Com-T inhibitor; 3 = MAO-B inhibitor; 4 
= dopamine agonist; 5 = other), Hand.: Edinburgh Handedness Inventory score, Med. 
admin: time from administration of levodopa to the UPDRS evaluation, Med. w/d: hours of 
medication withdrawal for OFF session (time is with respect to the UPDRS score). Patients 
were counterbalanced in the order in which they performed the task on or off. The session 
recorded first is underlined in the MoCA column. 
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Table II - Activity peaks associated with ET movements, compared with the control 
condition 
 
The coordinates (x,y,z) are in standard MNI stereotaxic space. Cluster sizes are reported in 
mm3. sc indicates that the peak is part of the same cluster as the peak listed immediately 
above in the table and that its size is therefore included in the preceding reported volume. 
The same abbreviations are used for tables 2-5. ET = externally triggered movements; SI = 
self-initiated movements; CTL = control movements; HC = healthy controls; OFF = 
patients off medication; ON = patients on medication; BA = Brodman area; aPFC = 
anterior PFC; DLPFC = dorsolateral PFC; PMC = premotor cortex; PPC = posterior 
parietal cortex; pPFC = posterior PFC; SMA = supplementary motor area; SPL = superior 
parietal lobule; VLPFC = ventrolateral PFC. *P < 0.001 non-corrected for multiple 
comparisons. 
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Table III - Activity peaks associated with SI movements, compared with the control 
condition 
 
Abbreviations as in Table II. 
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Table IV - Activity peaks associated with SI movements, compared with ET 
movements 
 
Abbreviations as in Table II. 
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Table V - Inter-group comparisons for the ET versus control, SI versus control, and SI 
versus ET contrasts between healthy participants, patients on and patients off 
medication 
 
Abbreviations as in Table II. 
 
  
	  	  	  	  	  
75	  
Chapter 4: Levodopa, disease asymmetry and hand proficiency 
 
 The focus of the next chapter is the interaction between the effects of levodopa, left 
and right hand movements and disease asymmetry. Based on the results of left and right 
hand movements from healthy young adults, we wanted to look more closely at the 
differences in the activation patterns of regions involved in the cortico-striatal circuits when 
patients with PD perform left and right hand movements. In our previous study we had 
demonstrated that activity of the putamen plateaued for movements of the left hand, 
whereas when participants used their right hand, activity in the putamen increased 
incrementally for control, ET, and SI movements, respectively (Francois-Brosseau et al., 
2009). We had suggested that these differences were related to hand proficiency. The goal 
of the following section was to examine the effect of levodopa on the differences between 
right and left hand movements, with a specific emphasis on disease asymmetry. As will be 
explained in the following paragraphs, we show that levodopa has an asymmetrical effect 
on the cortico-striatal circuit regions during SI and ET movements. Although the patients 
that participated in our protocol were right handed and affected more severely on their left 
side, we provide intriguing results that suggest a relationship between the asymmetrical 
effect of levodopa and disease asymmetry and/or hand proficiency.  
 
Differential effects of levodopa on neural activation patterns underlying movements of 
right and left hands in Parkinson’s disease  
Martinu, K., Nagano-Saito, A., Fogel, S., Monchi, O. 
 
Will be submitted shortly to Movement Disorders. 
 
Abstract 
 
PD is a neurodegenerative illness often characterized by asymmetrical symptoms. 
However, the cerebral correlates underlying symptom asymmetry are still not well 
understood and the effect of levodopa on the cerebral correlates of disease asymmetry have 
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not been investigated. In this study, right-handed PD patients performed SI, ET and 
repetitive control (CTL) finger movements with both their right and left hands during fMRI 
to investigate asymmetrical effects of levodopa on the hemodynamic correlates of finger 
movements. Patients completed two experimental sessions (with a minimum of 12h 
levodopa withdrawal): OFF and ON medication (regular dose of levodopa 1h prior to 
testing). We compared the effect of levodopa on the neural activation patterns underlying 
the execution of both more affected and less affected hand for SI and ET movements. Our 
results show that there were significant increases in activity after levodopa administration in 
regions of the motor cortico-striatal network when patients perform SI and ET movements 
with their left hand. When patients use their right hand, significant increases were observed 
between ON and OFF, only in the cerebellum during SI movements. As our patients were 
mainly affected more severely on their left side, levodopa may help provide additional 
dopaminergic input for left hand movements perhaps because it was more affected in this 
sample. These results suggest that the impact of reduced dopamine in the cortico-striatal 
system and the action of levodopa treatment is not symmetrical in the treatment of PD 
symptoms. 
 
Introduction 
 
 PD is a neurodegenerative illness whose cardinal symptoms are rigidity, tremor and 
bradykinesia. Symptoms often manifest more severely on one side of the body, and this 
lateralization persists throughout the duration of the disease (Hoehn & Yahr, 1967; Djaldetti 
et al., 2006). It has been suggested that symptoms begin (and remain more pronounced) 
more frequently on the dominant side of the body (Uitti et al., 2005; Yust-Katz et al., 2008; 
van der Hoorn et al., 2011). The underlying physiological and functional cerebral substrates 
of disease asymmetry in PD are not well understood. Importantly, the interaction of 
levodopa with the hand being used and symptom asymmetry has yet to be fully understood. 
Here we used SI and ET movements during fMRI to investigate the effect of levodopa on 
the neural patterns underlying movements of asymmetrically affected dominant and non-
dominant hands. 
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 The involvement of cortical regions and the basal ganglia in movement has long 
been documented (Deecke et al., 1969; Romo et al., 1992; Schultz & Romo, 1992; Jenkins 
et al., 2000). For right-handed individuals, movements of the left hand lead to greater 
increases in activity in motor areas than right hand movements (Mattay et al., 1998), and 
cortical, subcortical and cerebellar task-related activity has been shown to decrease with 
automaticity (Wu et al., 2004). Although patients with PD can also reach movement 
automaticity, they show greater increases in cortical and cerebellar activity than healthy 
controls when doing so (Wu & Hallett, 2005). We have previously shown that regions 
implicated in the motor cortico-striatal circuit (putamen, thalamus and PMC) are involved 
in both SI and ET movements (Francois-Brosseau et al., 2009; Martinu et al., 2012). More 
specifically, in young healthy adults, we have shown that activity of the putamen increases 
during repetitive control, ET and SI movements performed with the right hand. When using 
the non-dominant (left hand), however, activity of the putamen plateaued for both ET and 
SI movements. We suggested that the gradual involvement of the putamen during right hand 
movements is masked by the lack of proficiency of the non-dominant hand (Francois-
Brosseau et al., 2009).  
 When dopamine levels are deficient, such as in PD, dopamine replacement therapy 
such as levodopa and apomorphine can restore motor-related activity (Jenkins et al., 1992; 
Haslinger et al., 2001; Feigin et al., 2002). We have previously shown that the effect of 
levodopa in PD leads to an increase in activity in the putamen whether movements are SI or 
ET performed with the dominant hand in right-handed PD patients (Martinu et al., 2012). 
We did not, however, investigate the effect of levodopa on the neural patterns linked to the 
non-dominant hand.  
 The goal of the present study was to examine the effect of levodopa on the neural 
activation patterns underlying asymmetrically affected left and right hand movements. We 
hypothesized that levodopa may lead to an increase in activity in the motor cortico-striatal 
network during more affected-side hand movements. Consistent with our previous work, we 
further hypothesized that this effect would be equivalent for both SI and ET movements (i.e., 
not task-specific). In right-handed patients with more pronounced symptoms on the non-
dominant side, this would imply that levodopa might selectively act on movements of the 
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left hand, perhaps compensating for symptom severity. Understanding the interaction 
between levodopa and disease asymmetry would allow for new perspectives on levodopa 
mechanisms and subsequent research and treatment of asymmetrical symptoms.    
 
Methods 
 
Participants 
 
 Informed consent was obtained from all participants. The protocol was approved by 
the Joint Ethics Committee of the “Regroupement Neuroimagerie Quebec (RNQ)”, 
following the guidelines of the Tri-Council Policy Statement of Canada, the Civil Code of 
Quebec, the Declaration of Helsinki and the code of Nuremberg. 
 Twelve right-handed patients diagnosed with PD [mean age 62.89±6.70 (SD), 6 
women] participated (Table 1). All PD participants met the UK brain bank criteria (Hughes 
et al., 1992) for the diagnosis of idiopathic PD. Motor disability of patients with PD was 
mild to moderate severity, according to the Hoehn and Yahr staging criteria (Hoehn & Yahr, 
1967). Patients presenting any other neurological or psychiatric disorder were excluded. 
Handedness was assessed with the Edinburgh Handedness Inventory (mean 91.57±14.47), 
early signs of dementia were assessed using the MoCA (Nasreddine et al., 2005) (mean 
OFF 27.55±1.51, ON 26.92±1.88), and symptoms of depression in all participants was 
measured using the BDI-II (mean 12.58±11.74). At each session, the motor symptoms were 
measured with the UPDRS-III (OFF: 31.17±4.87 and ON: 23.42±6.95, score out of 156; the 
UPRDS form used for these evaluations is included in Appendix III). Left and right 
subsections were separated to give left and right UPDRS scores (average OFF: 10.9L/9.9R 
and ON: 9.0L/7.0R). In addition to levodopa, some patients also regularly took other anti-
parkinsonian drugs such as COMT inhibitors (n=5), MAO-B inhibitors (n=6), dopamine 
agonists (n=3) and others (n=3). Patients remained off these other medications for both the 
ON and OFF sessions.  
 
Procedure 
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 All patients came for two counterbalanced scanning sessions (one OFF medication, 
one ON levodopa), and were asked to withdraw from all anti-parkinsonian medications for a 
minimum of 12 hours prior to each appointment. Participants remained off medications for 
the OFF session. For the ON session, participants took their usual dose of levodopa 1 hour 
prior to the beginning of MRI acquisitions. All participants practiced three blocks of the 
finger-movement task (for a total of 9 repetitions of each condition) prior to the scanning 
session to ensure they were comfortable performing it in the scanner.  
 
Task 
 
 Participants performed SI, ET and CTL finger movements using left and right hands 
separately during functional MRI acquisitions in a pseudo-randomised order across runs, in 
both ON and OFF conditions. This task was identical to that previously described (Martinu 
et al., 2012). Each block began with written instructions, displayed for 2.5s, followed by the 
appearance of five squares oriented in a horizontal row on the screen, each corresponding to 
a button on the response box. Participants used all fingers except for the little finger (where 
1 was the thumb and 4, the ring finger); the square corresponding to the little finger was 
displayed for hand positioning, but remained inactive. The squares displayed on the screen 
turned green to indicate when a particular button should be pressed, and turned yellow for 
the duration of the button press. In the control condition, participants were instructed to 
repeatedly press a single button chosen at random for the duration of the block. In the ET 
condition, participants followed a randomly generated sequence. Finally, in the SI condition, 
participants generated their own sequences of finger movements. Participants were 
instructed to avoid pressing the same button consecutively in the SI task (this was 
considered an error), and to refrain from automatic (e.g., 1-2-3-4 or 4-3-2-1) or repeated 
sequences. For all tasks, participants were instructed to keep a comfortable, regular pace. 
Task conditions alternated at random after 20 button presses. An incorrect selection resulted 
in an error, and the corresponding square turned red to provide feedback. 
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fMRI 
 
Data acquisition. Participants were scanned using a 3T Siemens TIM Trio MRI scanner at 
the Functional Neuroimaging Unit (UNF) of the Centre de Recherche de l’Institut 
Universitaire de Gériatrie de Montréal (CRIUGM). Each scanning session (ON and OFF) 
comprised a T1-weighted three-dimensional volume acquisition (voxel size 1mm3) for 
anatomical localization, followed by four T2*-weighted functional echoplanar acquisitions 
with BOLD contrast. Each run consisted of 146 frames of 43 slices (matrix size 128x128, 
voxel size 2.34 x 2.34 x 3mm) acquired at a repetition time of 3.5 seconds. 
Data analysis. Data analysis was performed using fmristat software and minctools (Worsley 
et al., 2002) using a similar analysis strategy to our previous studies (Francois-Brosseau et 
al., 2009; Martinu et al., 2012), and was based on a linear model with correlated errors. 
After discarding the first three frames, all images were realigned to the fourth frame for 
motion correction and smoothed using a 6 mm full width half-maximum (FWHM) isotropic 
Gaussian kernel. The design matrix of the linear model was first convolved with a 
difference of two gamma hemodynamic response functions timed to coincide with the 
acquisition of each slice. The linear model was then re-estimated using least squares to 
produce estimates of effects and their standard errors. The resulting effect and standard 
effect images as well as anatomical images were spatially normalized using the ICBM152 
atlas (Collins et al., 1994; Zijdenbos et al., 2002). In a second step, runs and subjects were 
analyzed using a mixed-effects linear model. A random-effects analysis was performed by 
first estimating the ratio of the random-effects variance to the fixed-effects variance, and 
then regularizing this ratio using spatial smoothing with a Gaussian filter. The amount of 
smoothing was chosen to achieve 100 effective degrees of freedom (Worsley, 2005). 
Within-session analyses (SI vs. CTL, ET vs. CTL, SI vs. ET) were performed by direct 
comparison using the effects and standard deviation images; all peaks at a significance of p 
< 0.05 corrected and p < 0.001 uncorrected (marked by an asterisk) are reported in the 
supplemental material. Between-session analyses (ON vs. OFF) were performed by direct 
comparisons using the effects and standard deviations images of all participants in both 
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drug conditions. All peaks at a significance of p < 0.001 uncorrected with a cluster size > 
100mm3 are reported in tables VIII and IX.  
 
Results 
 
Clinical scores: 
 
There was no significant effect of session order and no statistical differences between 
MoCA scores ON and OFF. There were no significant correlations between MoCA or BDI-
II scores and behavioral performance during the finger-movement task. Patients had 
significantly lower UPDRS scores ON than OFF (p = 0.005). Only one patient was more 
affected on the right side of the body, the other 11 patients were either left side 
asymmetrical or approximately even (Table VI). Levodopa did not affect symptom 
asymmetry.  
 
Behavioral performance during scanning: 
 
Reaction times. The mean reaction times for SI, ET and CTL tasks ON and OFF for the left 
and right hand are reported in Table VII. A 3-way repeated measures ANOVA comparing 
drug condition (ON/OFF), hand (left/right) and task (SI/ET/CTL) revealed a 3-way 
interaction (p = 0.034). A paired-sample t-test analysis showed that there were no statistical 
differences between ON and OFF sessions for either task (SI, ET or CTL movements) for 
the left or right hands. Patients ON medication had significantly longer reaction times for 
the left hand compared with the right hand in the CTL task (p = 0.017).  
 
Errors. The percentages of errors in SI, ET and CTL tasks ON and OFF for the left and 
right hands are reported in Table VII. A 3-way repeated measures ANOVA comparing drug 
condition, hand and task revealed an effect of task (p = 0.018) with more errors in the ET 
condition, but no effect of drug condition, hand or any significant interactions.   
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fMRI results: 
 
SI movements. When comparing patients ON and OFF levodopa administration (ON – OFF) 
for the SI vs. CTL subtraction (Figure 23, Table VIII), patients showed significantly 
increased activity in the right anterior prefrontal cortex (aPFC), left PMC, bilateral motor 
cortex, left superior temporal gyrus (STG) and anterior cingulate cortex in the ON condition 
when using the left hand. Significant subcortical increases in activity were also observed in 
the left putamen, bilateral thalamus and right cerebellum. For the right hand, patients ON 
showed significantly increased activity the right cerebellum only. Compared with the ON 
condition (OFF – ON), patients OFF showed significantly greater activity than ON only in 
the left aPFC when using the right hand. Within-session results for SI movements are 
reported in the supplemental material. 
 
ET movements. For the ET vs. CTL contrast, patients ON showed significantly greater 
activity than OFF in the left PMC, bilateral motor cortex and SMA, left STG and PPC, left 
putamen and right thalamus when using their left hand (Figure 23, Table IX). No significant 
activations were observed when using the right hand. Compared to the ON condition (OFF 
– ON contrast), patients OFF had significant increases in activity in the left aPFC and motor 
cortex when using their right hand, and no significant differences in activity for the left 
hand. All significant within-session peaks for ET movements are reported in the 
supplemental material. 
 
Discussion 
 
 The goal of this study was to examine the effect of levodopa on the neural patterns 
underlying asymmetrically affected dominant and non-dominant hand movements in 
patients with PD. To our knowledge, this is the first direct evaluation of the impact of 
levodopa administration on behavioral and cerebral laterality. We found that regions 
involved in the motor cortico-striatal network (motor and pre-motor cortex, SMA, putamen 
and thalamus) and the cerebellum showed significant increases in activity ON vs. OFF 
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when participants used their left hand (Figure 23). In contrast, only the cerebellum showed 
significant differences ON vs. OFF when participants used their right hand. Our results 
suggest that levodopa does not affect brain activity symmetrically, but rather that it has a 
greater effect on the more affected non-dominant side. Although literature suggests that PD 
patients tend to be more affected on their dominant side (Uitti et al., 2005; Yust-Katz et al., 
2008; van der Hoorn et al., 2011), the patients that participated in this study were mainly 
affected on the left non-dominant side of the body. There are two possible interpretations 
that are not necessarily mutually exclusive. First, as non-dominant hand movements are less 
automatic than dominant hand movements (Mattay et al., 1998), levodopa may provide 
additional resources necessary to execute the less automatic left hand movements. 
Alternatively, levodopa may have a stronger effect on left hand movements because it was 
the most affected side in our patient cohort.  
	  
Figure 23: Location of peaks for SI – CTL (top) and ET – CTL (bottom) movements 
for sessions ON vs. OFF 
Anatomical images shown are the average of the T1 acquisitions of all patients transformed 
into stereotaxic space. The functional peaks are shown for t-stat values between 3 and 6. 
 Levodopa has been shown to have an effect on the amplitude of the BOLD signal as 
well as a “focusing effect” of the spatial distribution of activity (Ng et al., 2010). The 
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authors suggested that levodopa would help normalize the spatial distribution of activity 
observed in PD patients to that of control participants, possibly through an increase in 
signal-to-noise ratio by dopamine (Winterer, 2006). In relation with this focusing theory, we 
speculate that dopamine facilitates the activation of brain regions necessary for the 
generation of movements with the non-dominant or more affected limb. Asymmetrical 
effects after levodopa administration have been previously observed by PET at rest; Feigin 
et al. (2001) showed that levodopa decreased the PDRP of brain metabolism by suppressing 
metabolic activity in the left motor cortex, putamen, right thalamus, and bilateral cerebellum. 
Laterality effects were partially attributed to low statistical power, but the authors 
speculated that the least affected side might have preferentially responded to levodopa 
because the nigrostriatal dopaminergic terminals of that side were less degenerated. The 
discrepancy between this study and our results likely stems from the comparison between 
the effect of levodopa on brain metabolism at rest and during the performance of a motor 
task. Another group recently investigated the effect of a single dose of levodopa on a 
unimanual and bimanual grip task during fMRI in PD patients and healthy controls (Kraft et 
al., 2009). Levodopa significantly increased activity in the thalamus and putamen during 
bimanual movements. Although left side movements additionally recruited the ventrolateral 
thalamus, no significant differences between ON and OFF conditions were observed 
between the two hands. Although gripping movements may solicit different neural 
processes, these results strongly suggest that the effect of levodopa on dominant and non-
dominant hand movements is not symmetrical. 
 Asymmetrical degeneration of dopaminergic neurons in the substantia nigra 
underlies symptom asymmetry in PD (Kempster et al., 1989). It has been shown that the 
lateral ventricle contralateral to the more symptomatic side is enlarged in PD patients with 
asymmetrical symptoms (Lewis et al., 2009), and cognitive disruption often is consistent 
with the symptomatic hemisphere (Verreyt et al., 2011). For example, left motor 
dysfunction and a smaller substantia nigra volume have been shown to be associated with 
poorer spatial memory (Foster et al., 2008). Furthermore, responses to levodopa have been 
shown to vary throughout the course of the disease. More specifically, responses tend to be 
mild and long-lasting in the early stages of PD, followed by greater responses with shorter 
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duration times in the later stages, and ending in abrupt on and off switches (Duvoisin, 1989). 
This can be further applied to the asymmetry of the disease between the two hemispheres; 
asymmetrically affected hemispheres represent different stages of the disease, suggesting 
that the response to levodopa on the left and right sides of the body will vary depending on 
the patients’ asymmetry. Using four different tapping tasks, one study demonstrated that the 
more affected side showed reduced response latency, greater magnitude of improvement 
and shorter response duration to an infusion of levodopa (Rodriguez et al., 1994). In 
addition, another study showed the more affected side to have a delayed response onset after 
oral levodopa administration (Kumar et al., 2003). Based on the timing of our fMRI 
acquisitions (1h after levodopa administration), it is possible that the effect observed 
between ON and OFF is related to the differences in levodopa response of the more and less 
affected hemispheres. Taken together, the asymmetrical effect of levodopa observed in our 
study could reflect the different disease stages between the two hemispheres.  
 Because most patients in our protocol are more severely affected on their non-
dominant side, asymmetrical effects of levodopa could also be due to hand proficiency. 
Using SI, ET and control movements in a study with young healthy right-handed 
participants, we have shown that non-dominant (left hand) movements recruit the putamen 
to a greater extent than right hand movements, suggesting that greater recruitment is 
necessary to compensate for a lack of automaticity (Francois-Brosseau et al., 2009). Based 
on these previous results, we proposed that in healthy individuals, the increase in putamen 
activity reached a plateau when using the left non-dominant hand, whereas gradual 
increases in activity could be observed from control to ET to SI movements when using the 
right hand. In patients with PD performing the same tasks with their right hand only, we 
have previously shown that differences in putamen activity between control, ET and SI 
tasks were reduced compared with older healthy controls, and that levodopa led to non-task-
specific increases in cortico-striatal activity (Martinu et al., 2012). This was in accordance 
with a study investigating arm-reaching movements during PET imaging that showed that 
levodopa increased motor task-related activity (Feigin et al., 2002). Taken together, the 
significant differences in activity observed when patients use their left hand could also 
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suggest that levodopa increases cortical and subcortical activity in the left hand condition 
due an increase in difficulty when using the non-dominant hand.  
 Although we cannot conclusively attribute the effect of levodopa to the hand used 
and/or disease asymmetry, the fact that levodopa has different effects on movements of the 
left and right hand has important implications for understanding the mechanisms underlying 
levodopa function and the treatment of asymmetrical PD symptoms. Follow-up studies with 
a full cross-over design including left- and right-handed patients with left- and right-
asymmetry will be necessary to further disentangle the relationship between levodopa’s 
effect on movements as a factor of handedness and symptom and cerebral lateralization. 
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Table VI: Demographics for the twelve patients with PD 
       MoCA UPDRS scores 
Patient Gender Age Dur. Meds BDI-II Hand
. 
(On/Off) Total (On/Off) Left/Right (On) Left/Right (Off) 
1 F 69 2 1, 2 0 100 27/27 33.5/39.5 14/15 13/15 
2 F 51 5 1, 4 12 58 27/27 18.5/31 7.5/5 11.5/7 
3 M 67 2 1, 3 6 68.5 24/27 26/29 10/5.5 10.5/8 
4 M 69 9 1, 4, 5 27 89 28/25 23/34.5 7/7.5 11/10.5 
5 M 58 2 1, 2, 3 16 100 26/30 16.5/21.5 7/3.5 9/5 
6 M 54 5 1, 2, 3, 
5 
6 83.3 30/30 25.5/36 12/6.5 16.5/11.5 
7 M 68 3 1 6 100 27/28 26.5/27.5 9/8.5 9/7 
8 F 62 5 1, 3, 4 12 100 29/28 19.5/31.5 8/5 14/10.5 
9 F 68 11 1, 3, 5 15 100 26/27 25/31.5 8/7.5 9.5/10.5 
10 F 68 1 1, 2 42 100 24/- 21.5/27 5.5/11.5 4.5/14 
11 F 65 1 1, 2 3 100 29/26 26/36 13/6.5 13/11 
12 M 55 2 1, 3 6 100 26/28 12.5/29 7.5/2 9.5/8.5 
Mean  62.8
9 
4  12.6 91.5
7 
26.9/27.5 23.42/31.17 9.0/7.0 10.9/9.9 
SD   6.6 3.2   11.7 14.5 1.9/1.5 6.9/4.9 2.6/3.5 3.1/2.9 
 
Dur., years since illness onset; Med., parkinsonian medication (1, levodopa; 2, 
COMT inhibitor; 3, MAO-B inhibitor; 4, dopamine agonist; 5, other). 	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Table VII: Mean reaction times (SD) and percent errors for SI, ET and CTL 
movements for left and right hand movements of patients OFF and ON medication 
  
Mean RT (SD) in ms Errors (%) 
  
SI ET CTL SI ET CTL 
OFF LH 845 (122) 1107 (220) 713 (122) 3.38 8.78 0.64 
  RH 842 (168) 1106 (303) 717 (118) 2.87 8.92 0.76 
ON LH 872 (116) 1138 (136) 787 (133) 2.62 8.16 1.55 
  RH 870 (150) 1149 (171) 746 (168) 2.55 10.96 1.48 
 
 
Table VIII: Activation peaks between patients ON and OFF performing SI compared 
with CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cl. 
ON > OFF                         
aPFC 46/10 R 44 48 16 3.50 104 - - - - - 
PMC 6 L -56 2 40 4.00 432 - - - - - 
Motor 6 L -28 -18 54 3.52 112 - - - - - 
  
R 24 -14 72 3.76 232 - - - - - 
STG 42 L -64 -28 12 3.44 104 - - - - - 
Cingulate 32 L -14 10 36 3.55 128 - - - - - 
  
R 16 12 36 3.97 152 - - - - - 
Putamen 
 
L -24 10 10 3.57 312 - - - - - 
   
-28 -18 4 3.83 752 - - - - - 
Thalamus 
 
L -18 -18 -4 3.60 112 - - - - - 
  
R 6 -18 10 3.52 448 - - - - - 
Cerebellum   R 40 -78 -28 4.01 392 30 -54 -58 4.54 304 
OFF > ON                         
aPFC 10 L - - - - - -12 48 16 3.71 112 
 
The coordinates (x,y,z) in standard Montreal Neurological Institute stereotaxic space for all 
significant activation peaks for SI compared with CTL movements. Cluster sizes are in mm3.  
BA, Brodmann area; R/L, right/left; aPFC, anterior prefrontal cortex; PMC, pre-motor 
cortex; STG, superior temporal gyrus. 
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Table IX: Activation peaks between patients ON and OFF performing ET compared 
with CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cluster 
ON > OFF                         
PMC 6 L -58 4 32 3.58 128 - - - - - 
Motor 6 L -28 -18 54 3.59 248 - - - - - 
  
R 24 -18 54 3.55 128 - - - - - 
SMA 6 L -6 -6 54 3.82 928 - - - - - 
  
R 4 -22 52 3.74 928 - - - - - 
STG 42 L -64 -28 10 3.76 104 - - - - - 
PPC 40 L -46 -44 46 3.57 112 - - - - - 
Putamen 
 
L -24 6 12 3.59 264 - - - - - 
Thalamus   R 8 -14 8 3.80 312 - - - - - 
OFF > ON                         
aPFC 10 L - - - - - -12 50 16 3.70 168 
Motor 6 L - - - - - -20 -8 68 4.58 312 
 
The coordinates (x,y,z) in standard Montreal Neurological Institute stereotaxic space for all 
significant activation peaks for SI compared with CTL movements. Cluster sizes are in mm3.  
BA, Brodmann area; R/L, right/left; PMC, pre-motor cortex; SMA, supplementary motor 
area; STG, superior temporal gyrus; PPC: posterior parietal cortex; aPFC: anterior 
prefrontal cortex. 
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Chapter 5: Discussion 
 In this thesis, we have described the effect of levodopa on the patterns of brain 
activity during SI and ET movements of the left and right hands. Globally, our results imply 
that (1) the effect of levodopa on the putamen’s activity does not seem specific to SI and ET 
movements, (2) patterns of hyper-activity observed in PD patients are not improved by 
levodopa, and may rather be related to long-term levodopa treatment (3) that levodopa has 
different effects on left and right hand movements, related to hand proficiency and/or 
disease asymmetry, and we have argued that (4) the increases in activity often observed in 
the cerebellum of PD patients using neuroimaging techniques cannot be conclusively 
attributed to compensatory mechanisms. These results have important implications for the 
treatment of PD; they suggest that although levodopa has unquestionable benefits for motor 
symptoms, reflected by the improvement of UPDRS scores and its effect on the activity of 
regions involved in the motor cortico-striatal circuit, it has no beneficial effect on cognitive 
processes. Levodopa may in fact even promote unwanted increases in activity in regions 
such as the VLPFC and the cerebellum, contributing to the eventual development of side 
effects such as dyskinesias. 
 Several topics warrant further discussion. The first is a discrepancy between the 
cortico-striatal and cortico-cerebellar involvement in SI and ET movements in our 
protocols; one model in particular suggests that the processes underlying SI and ET 
movements are more separate. Secondly, we have investigated whether there are any 
correlations between cerebral activity and performance. We are also in the process of 
performing additional analyses, such as the functional connectivity between regions of the 
cortico-striatal and cortico-cerebellar circuits. We will finally present some drawbacks to 
the protocols described in this thesis, as well as different avenues for future research. 
 First of all, there is a discrepancy with some models of basal ganglia and cerebellar 
activity in SI and ET movements, mainly due to the differences between tasks. One study in 
particular examined internally guided and externally guided movements performed by a set 
of twins discrepant for PD (Lewis et al., 2007). The proposed model for the involvement of 
the basal ganglia and cerebellum in their internally guided and externally guided tasks 
differs significantly from our observations. More specifically, the authors suggest that 
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externally guided movements are primarily controlled by the cerebellar circuits, whereas 
internally guided movements are mainly controlled by the cortico-striatal circuits. Changes 
in activity in selected regions of interest (ROIs) suggest that the PD-affected twin is mainly 
impaired on the internally guided task. In contrast, we have shown that the basal ganglia, 
more specifically the putamen, are involved in both SI and ET movements, although the 
involvement is more substantial for SI movements. In our protocols, patients with PD show 
significant cortico-striatal decreases in activity during both SI and ET tasks. It is important 
to note, however, the differences in the tasks being performed. In our protocol, the SI and 
ET properties apply to every individual button press. This means that during the ET task, 
each button is pressed according to the display, one by one. The SI task is a pseudo-random 
set of button-presses chosen by the participant, again one by one. On the other hand, the IG 
and EG tasks used in Lewis et al. are a sequence of a series of four finger-to-thumb 
movements and wrist opening and closing, and it is the start of this sequence that is cued 
either internally or externally. Another important consideration is the contrast used during 
analyses. Whereas we compared SI and ET movements to a repetitive button-repeat control 
task, the IG and EG movements described are compared to rest. In general, then, although 
our results seem to be in contradiction, the discrepancies can be explained by a difference in 
task. Nonetheless, if the task suggested by Lewis et al. can truly dissociate between cortico-
striatal and cortico-cerebellar circuits, it provides potential an additional framework that 
could be used with TMS, as suggested in chapter 2, to test whether activity in the 
cerebellum is compensatory or pathophysiological. 
 We have performed additional analyses correlating the brain activity patterns during 
SI and ET movements of the left and right hand with reaction times as a correlate; these 
analyses have not been included in the articles because results did not lead to any consistent 
findings. Although speed was not the purpose of our task, there were no significant 
differences in reaction times between patients ON and OFF. Additionally, there was no 
evidence that the VLPFC/insula region would consistently correlate positively or negatively 
with reaction times. Only when patients OFF medication performed SI movements with 
their left hand was there a small cluster with a peak of t = 2.8 in the right VLPFC (Figure 
24). One possible analysis that would address this issue more specifically would be to select 
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a ROI that encompasses the peaks observed in chapter 3, and correlate the BOLD activity of 
this ROI not only with performance on the three tasks, but the number of errors as well. The 
number of errors performed overall was not high enough to give significant results on a 
whole-brain analysis, but could lead to interesting results when focusing on a single ROI 
such as the VLPFC/insula. The lack of consistent significant correlation between reaction 
times and cerebral activity before and after drug administration argues against the 
compensatory roles of regions such as the VLPFC and the cerebellum in our protocol.  
	  
Figure 24: fMRI BOLD activity correlating with performance in patients OFF 
medication performing SI vs. CTL movements 
Other methods than the comparisons of BOLD signal amplitudes could provide 
additional information. First, one could have also looked at the differences in spatial extent 
of activity between healthy participants and patients, but also between patients on and off 
levodopa. For example, Ng et al. (2009) have described changes in spatial variance after 
levodopa administration, suggesting that levodopa has a focusing effect on cerebral activity. 
Other types of methods include analyses of the changes in connectivity between regions.  
We are currently running a functional connectivity analysis using the putamen and the 
cerebellum as seeds. We are hoping that, along with the knowledge of anatomical 
connections between the cortico-striatal and cortico-cerebellar circuits, we can show strong 
functional connectivity between the cerebellum and regions of the motor cortico-striatal 
circuit. Firstly, we expect decreases in connectivity between regions of the cortico-striatal 
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and cortico-cerebellar loops in patients with PD compared with control participants. The 
main question, however, revolves around the effect of levodopa on this connectivity. Would 
levodopa help re-establish the functional connectivity between regions of the cortico-striatal 
and cortico-cerebellar loop, or will it have no effect? Using structural equation modeling 
and multivariate autoregressive modeling, Palmer et al. (2009b) suggest that levodopa 
would at least partially restore some effective connectivity and temporal patterns in PD. 
One of the major drawbacks of the studies presented here is the limited sample size. 
We would have ideally recruited an additional 12 to 14 patients with a more equilibrated 
symptom lateralization (i.e. about half the patients with left and half with right side 
asymmetry) to be able to draw proper conclusions from the left vs. right study (chapter 4). 
A larger sample size could have allowed us to properly dissociate between hand proficiency 
and the effect of disease asymmetry. More specifically, four distinct groups of right-handed 
and left-handed patients affected on the left and right side would be ideal to fully dissociate 
hand proficiency from disease asymmetry. A sample of de novo patients would also allow 
the distinction between actual disease pathophysiology, and changes related to the long-
term use of dopaminergic medication. Another limitation of our studies and patient-oriented 
fMRI studies in general is the comparison of populations with possibly quite different 
hemodynamic properties. Dopamine receptors, for example, play different roles in cerebral 
vasculature; whereas D1-like receptors elicit vasodilation and hyperperfusion, D2-like 
receptors lead to vasoconstriction and hypoperfusion (Choi et al., 2006). Using arterial spin 
labeling (ASL), Fernandez-Seara et al. (2012) have shown that PD is characterized by 
cortical hypoperfusion. This is consistent with the global decrease in BOLD amplitude and 
cluster sizes in patients with PD reported in chapter 3. Levodopa also seems to have effects 
on the cardiovascular system that could lead to changes in CBF as well as blood-brain 
barrier permeability (Ohlin et al., 2012). Looking at cerebral vasoreactivity in PD, however, 
Krainik et al. (2012) suggest that there are no major hemodynamic differences between 
patients with PD before and after levodopa.  
 Several avenues of future research can be explored based on the projects described 
in this thesis. First, it would be interesting to disentangle the pathophysiological and 
compensatory roles of the cerebellum. For this, as briefly mentioned in chapter 2, one could 
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stimulate the cerebellum with excitatory and inhibitory TBS sequences before participants 
perform tasks that are known to specifically involve the basal ganglia and the cerebellum. 
With the motor learning model described by Doyon et al. (2003, 2009), if patients with PD 
have reached a sufficient level of performance, sequence learning tasks will selectively 
recruit the basal ganglia, whereas motor adaptation tasks will selectively recruit the 
cerebellum. If the cerebellum has a strong compensatory role, patients with PD would 
become impaired on sequence learning tasks after inhibitory TBS stimulation of the 
cerebellum. It must be noted that the cerebellum does not function uniformly; 
pathophysiology and compensation are most likely working together, and different regions 
of the cerebellum may have different roles to play in each of these. Second, another idea 
would be to further explore the relationship between levodopa, handedness and disease 
asymmetry. Although many studies suggest that there is a tendency for symptoms to 
develop on the dominant side of the body (Uitti et al., 2005; van der Hoorn et al., 2011; 
Yust-Katz et al., 2008), results have not proven to be very robust. Ideally, one would recruit 
a large number of PD patients that are left and right handed, and asymmetrically affected on 
the right and left side, as mentioned above, to be able to separate them into four groups of a 
sufficient size. A large dataset would also allow for more powerful correlation analyses 
between disease asymmetry, brain activity patterns and performance. Finally, adding 
acquisitions such as resting state BOLD, DTI and ASL would allow a further understanding 
of the mechanisms involved in PD pathophysiology. Resting state fMRI analyses could 
shed light on the difference in network activity between healthy participants and patients 
with PD. DTI would, in turn, allow us to compare white matter integrity of cortico-striatal 
and cortico-cerebellar circuits in these patients. Arterial spin labeling, finally, would give us 
information on the differences in cerebral blood flow and metabolism between healthy 
participants and patients with PD, allowing us to compare more accurately the differences in 
cerebral activations measured with BOLD fMRI in both populations. 
 In conclusion, we present results in this thesis that suggest that despite levodopa’s 
clear helpful effect on motor symptoms, it has no beneficial effect on cognitive processes, 
and that it may instead promote unwanted increases in activity cortical and cerebellar 
regions, which are possible related to the development of side effects.	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Appendix I 
 
Supplementary material:  
Differential effects of levodopa on neural activation patterns underlying movements of 
right and left hands in Parkinson’s disease  
Martinu, K., Nagano-Saito, A., Fogel, S., Monchi, O. 
 
 
Supplementary tables X – XIII list the all statistically significant in intra-session 
comparisons described in chapter 4. The statistical threshold was set to p < 0.05 correcting 
for multiple comparisons (t > 4.3 for a single voxel or a cluster size >550 mm3). Peaks 
within the basal ganglia, thalamus, and PFC that were observed in our previous studies 
(Francois-Brosseau et al., 2009, Martinu et al., 2012) were considered predicted and are 
reported at a significance of p < 0.001 uncorrected [indicated by an asterisk (*)]. 
 
Patients OFF. 
SI movements. Compared with control movements, when patients OFF performed SI 
movements (Table X) with their left hand, significant increases in activity were observed in 
the DLPFC, VLPFC/insula, PMC, motor and sensory cortex, SMA and PPC. Subcortical 
activations included the right putamen and thalamus, as well as the bilateral cerebellum. 
When patients OFF performed SI movements with their right hand, there were significant 
activations in the DLPFC, VLPFC/insula, PMC, motor cortex, SMA, PPC and visual cortex 
compared with control movements. Additionally, increases in subcortical regions were 
observed in the bilateral putamen, left thalamus and bilateral cerebellum. 
 
ET movements. Patients OFF performing ET (Table XI) movements with their left hand 
showed significant increases in activity in the VLPFC/insula, PMC, motor and sensory 
cortex, PPC, and visual cortex compared with control movements. Subcortical activations 
included the right putamen and bilateral cerebellum. 
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During right hand ET movements, patients OFF medication had significant increases in 
activity in the VLPFC, PMC, PPC and visual cortex compared to control movements, as 
well as in the bilateral putamen, thalamus and right cerebellum. 
 
Patients ON: 
SI movements. Compared with the control task, when patients ON performed SI movements 
(Table XII) with their left hand, there were significant increases in activity the bilateral 
aPFC, DLPFC, VLPFC, cingulate cortex, pPFC, inferior frontal gyrus, PMC, sensory cortex, 
SMA, PPC and visual cortex. Subcortical activations were additionally observed in the 
bilateral putamen, thalamus, STN and cerebellum. 
When patients ON performed the SI task with their right hand, significant increases in 
activity were observed in the DLPFC, VLPFC/insula, cingulate gyrus, PMC, motor and 
sensory cortex, SMA, and PPC compared with the control task. Subcortical activations were 
observed in the bilateral putamen, thalamus and cerebellum. 
 
ET movements. When patients ON performed ET movements (Table XIII) with their left 
hand, we observed significant increases in activity in the DLPFC, VLPFC/insula, PMC, 
SMA, sensory cortex, PPC and visual cortex compared to control movements. Additionally, 
subcortical activations included the bilateral putamen, thalamus, STN and cerebellum. 
When patients ON performed the ET task with their right hand, significant increases in 
activity were observed in the VLPFC/insula, PMC, motor cortex, SMA, PPC and visual 
cortex compared with the control task. Subcortical activations included the putamen, 
thalamus and cerebellum. 
 
 
  
Table X: Activation peaks for patients OFF performing SI versus CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cluster 
DLPFC 9,46 L -32 32 30 4.37 1248 -32 32 32 3.79 720 
  
R 34 36 28 4.84 1512 34 34 30 4.89 1000 
VLPFC/Insula 47/12,13 L -36 16 6 5.63 2056 -34 18 4 4.77 1304 
  
R 32 20 6 4.03 2048 34 20 6 3.49 2352 
PMC 6 L -28 -6 64 4.72 8808 -24 -12 58 5.28 10160 
   
-22 -4 50 4.99 8808 - - - - - 
   
-54 -2 40 3.88 728 - - - - - 
  
R 28 -4 58 6.64 38968 28 -4 56 6.01 7528 
   
52 8 24 5.64 4504 54 8 26 4.42 1888 
Motor 4 L - - - - - -38 -18 58 5.09 10160 
  
R 40 -16 64 5.38 38968 - - - - - 
Sensory 3 L -58 -18 36 3.84 968 - - - - - 
 
2 R 56 -18 30 5.69 38968 - - - - - 
SMA 6 L -6 0 48 4.21 8808 -6 -2 50 4.09 1776 
  
R 6 -2 48 4.09 664 - - - - - 
PPC 40 L -42 -38 36 4.55 9576 -42 -32 38 4.95 16616 
  
R 48 -32 48 6.04 38968 48 -34 44 6.64 13792 
   
38 -44 48 6.43 38968 
     PPC 7 L -22 -64 60 6.50 9576 -20 -64 60 6.40 16616 
   
-34 -48 52 4.52 9576 -36 -52 58 4.65 16616 
  
R 20 -66 60 5.36 38968 20 -68 60 5.39 13792 
   
26 -58 52 4.82 38968 - - - - - 
Visual 19 R - - - - - 32 -80 10 3.77 560 
 
18 R - - - - - -12 -86 -10 4.70 760 
Putamen 
 
L - - - - - -22 4 10 5.56 4936 
  
R 24 4 6 5.00 2048 24 2 8 4.52 2352 
Thalamus 
 
L - - - - - -16 -14 4 4.40 4936 
  
R 12 -14 2 3.60* 248 - - - - - 
Cerebellum 
 
L -28 -48 -24 4.70 5168 -30 -68 -22 4.08 920 
   
-26 -64 -50 4.86 2320 - - - - - 
   
-30 -44 -50 4.05 1048 - - - - - 
   
-6 -58 -16 3.98 5168 - - - - - 
  
R 8 -56 -10 4.00 5168 14 -70 -18 4.16 5232 
   
30 -54 -26 3.96 1672 30 -54 -26 5.18 5232 
      28 -48 -54 4.69 992 - - - - - 
 
The coordinates (x,y,z) in standard Montreal Neurological Institute stereotaxic space for all 
significant activation peaks for SI compared with CTL movements. Cluster sizes are in mm3. 
Sc indicates that the peak is part of the same cluster as the peak listed immediately above it. 
The following abbreviations are used for Tables 1 – 4. 
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BA, Brodmann area; R/L, right/left; aPFC, anterior prefrontal cortex; DLPFC, dorsolateral 
prefrontal cortex; VLPFC, ventrolateral prefrontal cortex; pPFC, posterior prefrontal cortex; 
IFG, inferior frontal gyrus; PMC, pre-motor cortex; SMA, supplementary motor area; PPC, 
posterior parietal cortex. 	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Table XI: Activation peaks for patients OFF performing ET versus CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cluster 
VLPFC/Insula 47/12,13 L -36 16 6 4.57 912 -34 18 6 4.37 640 
  
R 32 20 6 4.16 504 - - - - - 
PMC 6 L -54 0 42 4.48 1512 -50 -2 42 4.23 968 
   
-22 -4 50 4.74 2552 -24 -10 54 4.42 4032 
  
R 28 -4 56 6.48 6184 30 -4 58 5.58 5832 
   
52 6 34 4.50 3560 50 4 34 4.24 2168 
   
48 8 22 5.24 3560 44 6 24 4.41 2168 
Motor 4 R 40 -16 64 3.81 6184 - - - - - 
Sensory 3 L -58 -18 36 4.18 824 - - - - - 
  
R 48 -22 58 4.14 15624 - - - - - 
 
2 R 56 -18 30 4.71 15624 - - - - - 
   
- - - - - -6 0 50 3.66* 208 
PPC 40 L -36 -38 38 4.35 3032 -42 -34 38 4.77 8264 
  
R 48 -30 44 5.27 15624 42 -42 56 4.96 9824 
   
40 -44 56 5.24 15624 - - - - - 
 
7 L -16 -74 54 4.77 2072 -22 -64 60 5.22 8264 
   
-34 -50 52 3.79 3032 - - - - - 
  
R 28 -58 52 5.02 15624 28 -56 50 5.02 9824 
Visual 37 
 
- - - - - 44 -64 -12 4.13 5088 
 
19 L -28 -84 -14 4.30 4856 -24 -86 12 4.07 872 
  
R 34 -84 14 4.48 14032 30 -74 32 3.75 280 
   
- - - - - 32 -82 8 4.62 4080 
 
18 L -12 -86 -10 4.73 4856 -12 -86 -10 6.00 3424 
   
-24 -100 6 4.47 4856 - - - - - 
  
R 10 -78 -12 4.98 14032 - - - - - 
   
26 -94 10 4.50 14032 - - - - - 
 
17 R 12 -84 4 3.98 14032 - - - - - 
Putamen 
  
- - - - - -22 4 10 3.52 824 
  
R 24 6 6 4.47 680 24 2 10 3.82 552 
Thalamus 
 
L - - - - - -14 -20 12 3.21 824 
  
R - - - - - 14 -12 8 3.29 552 
Cerebellum 
 
L -34 -52 -26 4.27 3208 - - - - - 
   
-26 -62 -48 3.92 824 - - - - - 
    R 30 -54 -24 4.06 14032 30 -54 -26 4.48 5088 
 
Abbreviations as in Table X. 
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Table XII: Activation peaks for patients ON performing SI versus CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cluster 
aPFC (not A1) 10 L - - - - - -32 52 10 3.84* 144 
aPFC 46/10 L -38 38 20 3.81 3144 - - - - - 
  
R 42 48 22 3.79 6328 - - - - - 
DLPFC 9,46 L -42 32 32 4.72 3144 -42 30 32 4.80 1512 
  
R 30 36 28 6.40 6328 34 34 32 5.33 2272 
VLPFC/Insula 47/12,13 L -36 16 6 6.65 41128 -34 16 4 5.17 9144 
  
R 30 20 6 5.23 22096 30 20 4 4.82 6784 
Cingulate 32 L -12 12 38 5.15 82088 -8 10 46 4.83 55440 
  
R 8 16 38 5.65 82088 - - - - - 
pPFC 44,6 R 58 10 26 6.07 82088 - - - - - 
IFG*? 44 R 50 6 12 4.42 82088 - - - - - 
PMC 6 L -28 -8 58 6.12 41128 -24 -14 60 5.87 55440 
   
-54 0 40 6.51 41128 -54 0 42 5.46 1496 
  
R 26 -4 58 7.03 82088 20 -6 58 6.08 55440 
   
48 4 34 5.03 82088 52 8 24 5.12 1928 
Motor 4 L - - - - - -32 -18 70 5.98 55440 
Sensory 2 L -60 -22 34 5.35 22696 - - - - - 
  
R 56 -18 28 5.46 82088 - - - - - 
 
3 L - - - - - -42 -18 58 5.81 55440 
  
R 40 -24 50 7.03 82088 - - - - - 
SMA 6 L -6 8 48 5.87 82088 -6 -4 54 4.99 55440 
   
-4 -4 60 4.96 82088 -6 10 48 4.80 55440 
  
R 8 -4 66 4.29 82088 6 -4 54 4.07 55440 
PPC 40 L -44 -36 40 6.09 22696 -40 -34 52 5.63 55440 
   
-36 -48 48 5.21 22696 -36 -48 48 5.41 55440 
  
R 48 -28 46 7.45 82088 48 -30 46 6.45 21280 
   
36 -44 52 7.50 82088 40 -38 46 6.09 21280 
PPC 7 L -22 -64 60 7.07 22696 -34 -56 62 5.77 55440 
   
- - - - - -22 -66 60 7.27 55440 
   
- - - - - -20 -68 44 5.09 55440 
  
R 16 -66 50 6.56 82088 18 -70 58 6.93 21280 
   
- - - - - 40 -46 60 5.63 21280 
Visual 37 R 44 -60 -14 4.62 49984 - - - - - 
   
32 -64 -22 4.79 49984 - - - - - 
 
18 L -22 -88 12 4.29 464 - - - - - 
  
R 34 -84 4 5.38 49984 32 -84 2 4.23 736 
Putamen 
 
L -24 8 6 6.26 41128 -24 6 6 6.87 9144 
   
-26 -12 8 5.66 41128 - - - - - 
  
R 22 6 6 6.97 22096 22 10 4 6.73 6784 
Thalamus 
 
L -14 -16 10 6.18 41128 -10 -18 0 4.73 9144 
  
R 14 -16 6 6.67 22096 10 -16 0 5.17 6784 
STN 
 
L -8 -24 -2 4.88 41128 - - - - - 
  
R 8 -20 -4 5.49 22096 - - - - - 
Cerebellum 
 
L -26 -52 -26 6.52 49984 -28 -58 -56 4.17 2392 
   
-14 -66 -52 4.79 49984 -28 -60 -28 4.36 3048 
   
-2 -54 -6 5.01 49984 - - - - - 
  
R 10 -78 -16 5.12 49984 26 -54 -28 6.77 16392 
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42 -76 -26 4.60 49984 28 -54 -58 5.81 16392 
   
28 -54 -28 6.91 49984 16 -66 -54 4.34 16392 
   
26 -38 -38 4.18 49984 - - - - - 
      26 -52 -58 5.42 49984 - - - - - 	  
Abbreviations as in Table X. 	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Table XIII: Activation peaks for patients ON performing ET versus CTL movements 
      Left hand Right hand 
Anatomical area BA R/L x y z t cluster x y z t cluster 
DLPFC 9,46 L -30 34 26 3.76* 360 - - - - - 
  
R 30 36 28 5.01 1304 - - - - - 
VLPFC/Insula 47/12,13 L -34 16 8 5.56 13632 -32 20 6 4.78 768 
  
R 32 20 8 4.71 1232 
     PMC 6 L -52 0 42 7.25 21280 -52 0 42 5.91 2120 
   
-26 -8 56 5.82 7424 
     
  
R 58 10 26 4.60 45120 42 2 32 3.86 728 
   
26 -6 54 6.46 45120 32 -4 58 4.89 3008 
   
42 2 32 5.52 45120 - - - - - 
Motor 4 L - - - - - -32 -16 72 4.54 2672 
SMA 6 L -6 0 50 5.68 6248 -8 -2 52 4.11 552 
Sensory 3 L -60 -20 36 5.03 21280 - - - - - 
  
R 62 -16 34 5.18 45120 - - - - - 
   
42 -22 52 5.12 45120 - - - - - 
PPC 40 L -42 -38 38 5.75 21280 -42 -38 38 4.31 6448 
   
-36 -50 50 5.00 21280 -34 -50 46 4.34 6448 
  
R 36 -46 54 7.25 45120 34 -48 54 4.00 3072 
   
48 -30 48 6.50 45120 
     
 
7 L -22 -64 60 5.02 21280 -34 -56 62 4.69 6448 
   
- - - - - -22 -66 60 5.39 6448 
   
- - - - - -18 -76 54 4.91 6448 
  
R 18 -70 58 5.15 45120 20 -70 60 5.11 3072 
Visual 19 L -36 -64 -22 4.53 16152 - - - - - 
  
R 26 -72 36 4.31 45120 - - - - - 
 
18 L -24 -88 12 6.05 16152 - - - - - 
   
-20 -78 -16 4.62 16152 - - - - - 
  
R 34 -84 4 6.39 33856 34 -82 2 5.18 2208 
   
28 -80 -18 4.75 33856 - - - - - 
 
17 L -10 -92 -12 4.21 16152 - - - - - 
   
-6 -86 6 4.15 1184 - - - - - 
  
R 12 -82 2 4.95 33856 - - - - - 
Putamen 
 
L -24 8 8 5.76 13632 -24 6 6 4.34 1392 
   
-30 -6 2 5.18 13632 - - - - - 
  
R 24 2 8 6.05 12304 24 10 4 3.20* 8 
   
26 2 -4 4.21 12304 - - - - - 
Thalamus 
 
L -14 -16 4 5.70 13632 -14 -18 0 4.01* 456 
  
R 14 -14 4 5.30 12304 10 -18 -2 4.22 616 
STN 
 
L -10 -24 -2 4.74 13632 - - - - - 
  
R 6 -24 -6 4.71 12304 - - - - - 
Cerebellum 
 
L -34 -52 -26 4.89 16152 - - - - - 
   
-16 -64 -50 4.41 2776 - - - - - 
   
-32 -54 -58 4.50 2776 - - - - - 
  
R 10 -78 -18 4.78 33856 34 -66 -22 4.28 5736 
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28 -52 -26 5.24 33856 26 -54 -30 5.02 5736 
      28 -52 -58 5.12 1432 28 -52 -58 5.42 1552 
 
Abbreviations as in Table X. 	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Abstract 
 
While there are a number of functional neuroimaging studies that have investigated SI and 
externally generated movements, data comparing directly right and left hands in this context 
is very scarce. The goal of this study was to further understand the role of the basal ganglia 
and the PFC in the realm of SI and ET right and left hand movements. Young healthy right-
handed adults performed random, follow and repeat conditions of a finger moving task, 
with their right and left hands, while being scanned with fMRI. Significant activation of the 
DLPFC was observed when comparing the SI movements with the repeated control and ET 
movements when using either hand in agreement with its role in monitoring. The caudate 
nucleus activation was found during SI conditions compared with the control condition 
when either hand was used, showing that it is particularly involved when a new movement 
needs to be planned. Significant putamen activation was observed in all within-hand 
contrasts except for the ET vs. control condition when using the left hand. Furthermore, 
greater putamen activation was found for the left vs. the right hand during the control 
condition, but for the right vs. the left hand subtraction for the SI condition. Our results 
show that the putamen is particularly involved in the execution of non-routine movements, 
especially if those are SI. Furthermore, we propose that, for right-handed people performing 
fine movements, as far as putamen involvement in concerned, the lack of proficiency of the 
non-dominant hand may prevail over other task demands.  
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Introduction 
 
Many studies have looked into the differences in organization between SI and ET 
movements. The first studies in humans reporting significant differences between the two 
were surface electrode experiments that described the involvement of the SMA in SI, or 
voluntary, movements (Deecke et al. 1969). More recent studies, using fMRI, have 
explored this issue further. For example, Jenkins et al. (2000) found that when comparing 
SI movements to ET ones in a right hand finger extension task, the rostral SMA and its 
adjacent cingulate cortex, as well as the DLPFC were significantly activated (Jenkins et al. 
2000). Another study by Cunnington et al. (2002) showed that the basal ganglia were only 
significantly involved in a SI task, and not in the ET task when using their right hand. In 
accordance with these results, previous lesion studies in monkeys have shown that lesions to 
the putamen result in a reduced capacity to execute learned movements in the absence of 
external cues (Nixon and Passingham, 1998). Some of the first studies to investigate the role 
of the striatum in SI and ET movements were the single cell studies in monkeys perfomed 
by Romo et al., 1992 and Schultz and Romo, 1992. These studies found cells in both the 
caudate nucleus and the putamen with activity prior and during the execution of SI 
movements. Some of these cells fired only for SI movements while others fired for both SI 
and ET movements (Romo et al., 1992; Schultz and Romo, 1992). 
An important distinction, however, must be made between the movements of the right and 
left hand in humans. Mattay et al. (1998) showed that a simple task with the non-dominant 
hand induces increased ipsilateral cortical activity, comparable to a more complex task with 
the dominant hand. Although the more complex task was not performed with the non-
dominant hand, these results imply that the non-dominant hand recruits more ipsilateral 
cortical regions because of its lack of automaticity. Furthermore, a study of left hand 
movements by Taniwaki et al. (2003) showed that the basal ganglia-thalamo-motor loop 
plays a role in the rate control of SI movements, but not of ET movements. Most of these 
studies, however, examined only one hand, whether dominant or non-dominant, slightly 
differential tasks with each hand, or the effect of handedness on movement. Data comparing 
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the same task with the right and left hand directly, with an emphasis on the role of basal 
ganglia, however, is scarce. In the present fMRI study, right-handed young healthy adults 
had to perform a new motor task that included a SI random movement condition, an ET 
condition, and a repeated movement (control) condition with the left and right hands. The 
goal of this study was to further determine the specific contributions of the putamen, the 
caudate nucleus, the STN and the PFC during novel movements when using the dominant 
(right) and non-dominant (left) hands separately. We predicted that the movements of the 
left hand would be more driven by the cortex, and the movements of the right hand by the 
striatum. We also predicted that the differences in task difficulty would play a larger role in 
the use of the right hand compared to the left because movements of the dominant right 
hand are more automatic.  
 
Materials and Methods 
 
Subjects. Fourteen completely right-handed healthy subjects participated in the experiment 
(7 males, 7 females; mean age 22.6 ± 0.5 SD years; range, 22-24).  All subjects were free of 
neurological and psychiatric history and gave informed consent to the protocol, which was 
reviewed and approved by the Joint Ethics Committee of the Regroupement Neuroimagerie 
Québec (RNQ). Handedness was assessed with the Edinburgh Handedness Inventory. 
 
Tasks. Three different conditions of a finger movement task for each hand were performed 
during scanning: a SI random movement condition, an ET follow condition, and an ET 
repeat condition that was used as a control. During the whole task, the participants saw four 
blue squares, each square corresponding to a button on either the right or left response box; 
all fingers were used except for the thumbs, with a total of twenty finger presses per 
condition. Before each condition, instructions appeared on the screen for 2.5 seconds during 
which the subject was told which hand to use and which condition to perform.  
During the control condition, one of the squares would switch colors from blue to green, 
which would indicate that the corresponding button must be pressed. For the duration of 
every button-press, the square would turn yellow to show the subject’s response, and then 
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turn green again to illustrate that it is ready to be pressed again. This continued until the 
subject made twenty successful button-presses. The button to be pressed during the control 
task was randomly selected by the computer, and remained the same for the duration of the 
condition. For this task only a minimal response time was set to 300ms between two button 
presses so that subjects were forced to press continuously, and did not hold the button down. 
The ET follow condition began in the same manner as the control task, but the button to be 
pressed changed every time, and no given sequence of four finger presses was repeated 
within the same block. The subject therefore had to follow the sequence generated randomly 
by the computer, as one of the blue squares turned green one by one. Every button-press 
resulted in the corresponding square turning yellow if it was correctly pressed, or red if it 
was an incorrect selection.  
For the SI random condition, all four squares would turn green, and the subject had to 
generate his/her own sequence of button presses. Once again, as a feedback, the buttons 
pressed made the green squares turn yellow, after which the next button was ready to be 
selected. The program insured that no button was pressed twice in a row, and that no 
repeated sequence or pattern would occur. More specifically, pressing the same button twice 
in a row (e.g. 2-2) would be an error, indicated by the equivalent square turning red. We 
also asked the subjects to refrain from using common sequences such as 1-2-3-4 and 4-3-2-
1; or to repeat sequences twice in a row such as of 4-2-3-1-4-2-3-1. Such 4-button sequence 
was registered as an error.  
 
Functional Magnetic Resonance Imaging Scanning. Subjects were scanned using the 
Siemens Trio 3-Tesla MRI at the Functional Neuroimaging Unit of the CRIUGM.  Each 
scanning session began with a T1-weighted three-dimensional volume acquisition (voxel 
size, 1x1x1 mm3) for anatomical localization, followed by six T2*-weighted functional 
echoplanar acquisitions. Each run consisted of 80 frames with high spatial resolution based 
on the acquisition parameters used by Lehericy et al., (2005) in order to allow for good 
subcortical localization. Each frame contained 45 slices (TR = 4000 ms; FA: 90o; TE: 30ms; 
partial Fourier imaging 6/8; matrix, 128*128; voxel size, 2x2x2 mm3). 
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Data analysis. The methods for data analysis were the same as those used in our previous 
studies (Monchi et al., 2001, 2004, 2007) and made use of the fmristat software developed 
by Worsley et al. (2002). The first three frames in each run were discarded. Images from 
each run were first realigned to the fourth frame for motion correction and smoothed using a 
6 mm full width half-maximum (FWHM) isotropic Gaussian kernel. The statistical analysis 
of the fMRI data was based on a linear model with correlated errors. The design matrix of 
the linear model was first convolved with a difference of two gamma hemodynamic 
response functions timed to coincide with the acquisition of each slice. The correlation 
structure was modeled as an autoregressive process. At each voxel, the autocorrelation 
parameter was estimated from the least squares residuals, after a bias correction for 
correlation induced by the linear model. The autocorrelation parameter was first regularized 
by spatial smoothing and was then used to "whiten" the data and the design matrix. The 
linear model was re-estimated using least squares on the whitened data to produce estimates 
of effects and their standard errors. The resulting effects and standard effect files were then 
spatially normalized by nonlinear transformation into the Montreal Neurological Institute 
(MNI) standard proportional stereotaxic space, which is based on that of Talairach and 
Tournoux (1988), using the algorithm of Collins et al. (1994). Anatomical images were also 
normalized to the MNI space using the same transformation. In a second step, runs, sessions 
and subjects were combined using a mixed effects linear model for the data taken from the 
previous analysis. A random effects analysis was performed by first estimating the ratio of 
the random effects variance to the fixed effects variance, then regularizing this ratio by 
spatial smoothing with a Gaussian filter. The amount of smoothing was chosen to achieve 
100 effective degrees of freedom (Worsley et al., 2002, 2005). Statistical maps were 
thresholded at p<0.05 corrected for multiple comparisons for all peaks corresponding to a t> 
4.8 or a cluster size of > 800mm3 and at p <0.001 uncorrected for predicted peaks within the 
basal ganglia (indicated by a * in the tables). 
For each hand, the average BOLD signal obtained during the self-generated movement 
condition was compared with that of the ET condition and the control condition. Also, the 
ET condition was compared with the control condition, for a total of six contrasts. 
Furthermore, in order to investigate more precisely the difference between the two hands 
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the average BOLD contrast of the left hand vs. the right hand, and the right hand vs. the left 
hand was compared for each of the three conditions, producing another six contrasts.  
 
Results  
 
Behavioural  
 
Reaction times. In the SI condition, right hand response took an average of 504 ms, s.d. 60 
ms while left handed movements took 512 ms, s.d. 67 ms, and in the ET movements, the 
average reaction time was 739 ms, s.d. 40 ms for the right hand and 771 ms, s.d. 78 ms for 
the left hand. For both conditions, the right hand was significantly faster than the left hand 
(p<0.01). When considering both hands together, reaction times were significantly slower in 
the ET condition than in the SI condition (p<0.0001).  
Percentage of Errors.  During the SI movements the participants made on average 
0.9±0.4% errors with the right-hand and an average of 1.0±0.8% errors with the left one. 
During the ET condition, participants made an average of 1.8±1.3% errors with the right 
hand and an average of 2.1±1.1% errors with the left one. There were significantly less 
errors in the SI than in the ET condition (p<0.0001), but the number of errors were not 
significantly different between the two hands (p > 0.1). It should be noted here that, in the 
ET condition, there is only one selection possible on each trial (the one indicated), while in 
the SI condition there is more than one possible selection per trial, as long as it is not part of 
a repetitive sequence. The error rates for both conditions were very low after training (i.e. 
during the scanning session). Finally, there were no errors in the control condition with 
either hand.  
 
fMRI 
 
A summary of the major results for the putamen, the caudate nucleus, the STN and the 
DLPFC is given in Table XX. It should be noted that while high resolution parameters were 
used for this study (128*128 matrix resolution, voxel size, 2x2x2 mm3), it may still be 
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difficult to determine with certainty whether the activations reported below that encompass 
the STN are actually focused solely in this nucleus. This is partly due to the fact that a 
standard normalisation technique was used (Nieto-Castanon et al., 2003). However, the 
coordinates of the activity clusters observed coincided well with the delimitation of the STN 
in the Talairach and Tournoux atlas and with those reported in previous fMRI studies 
focusing on this nucleus (Aron and Poldrack 2006; Monchi et al., 2006; Ray et al., 2008). 
 
1. SI movements compared with the control condition 
Right hand. Comparison of SI movements with the control condition when using the right 
hand demonstrated significantly increased bilateral activity in the mid-dorsolateral PFC 
(area 9, 46, Figure 28), the SMA (area 6), the PMC (area 6), the primary sensory cortex 
(areas 1, 3), the motor cingulate cortex (area 24), and the PPC (Brodmann area (BA) 7 and 
40), while contralateral significant activations were found in the insula, the motor cortex 
(area 4), and the adjacent superior parietal lobule (area 5) (Table XIV). Subcortically, 
significant activation was found bilaterally in the putamen (Figure 26A), the caudate 
nucleus (Figure 28A), the STN (Figure 27A), as well as the left thalamus. 
Left hand. Comparison of SI movements with the control condition when using the left hand 
showed significant bilateral cortical peaks in the dorsolateral PFC (areas 9, 46, Figure 28), 
the motor cingulate cortex (area 24), the insula, the SMA (area 6), the PMC (area 6), and the 
posterior parietal area (areas 7 and 40). Significant increased activity also occurred 
contralaterally in the primary sensory cortex (areas 1, 3) and the superior parietal lobule 
adjacent to the motor cortex (area 5) and significant ipsilateral activation was found in the 
primary motor cortex (PMC) (area 4). As was the case with the right hand, there was a 
significant increase of subcortical activity bilaterally in the putamen (Figure 26A) and the 
caudate nucleus (Figure 28A), as well as in the left STN (Figure 27A) (Table XIV).  
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Figure 25: Location of the putamen peaks in the various subtractions. 
The anatomical images shown are the average of the T1 acquisitions of all of the 
participants transformed into stereotaxic space. (A) SI vs. control condition. Significant 
putamen activation is shown bilaterally for the left hand (left column) and for the right hand 
(right column). (B) ET vs. control condition. Bilateral significant putamen activation is 
shown for the right hand but none is observed for the left hand. (C) The location of the 
contralateral putamen significant activation is shown for each hand in the SI vs. ET 
condition. (D) For the SI condition, the right column shows the location of the significant 
left putamen activation in the right vs. the left hand; no significant putamen activation is 
observed in the left vs. right hand comparison. (E) For the ET condition, the location of the 
right putamen peak is shown for the left vs. right hand comparison in the left column, 
similarly for the right putamen peak for the right vs. left hand comparison in the right 
column. (F) For the control condition, the left column shows the location of the significant 
right putamen activation in the left vs. the right hand; no significant putamen activation is 
observed in the right vs. the left hand comparison. 
2. ET compared with the control condition  
Right hand. In the comparison of ET movements with the control condition when the right 
hand was used, a significant increase of activity was observed bilaterally in the motor cortex 
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(area 4), the PPC (area 7), and the motor cortex (area 4). Contralateral significant activation 
(i.e. on the left) was found in the SMA (area 6), the PMC (area 6), the primary sensory 
region (areas 1, 2, 3), and the PPC (area 40), (Table XV). Subcortically, significantly 
increased activity was found in the putamen bilaterally (Figure 26B), but not in the STN 
even at a low threshold of 0.01 uncorrected (Table XV).  
Left hand. For the same comparison in the left hand, significant increased activity was 
observed bilaterally in the SMA (area 6), the motor cortex (area 4), and the PPC (areas 7 
and 40). Significant activations were also observed in the primary sensory areas (areas 
1,2,3) contralaterally (i.e. in the right hemisphere), and in the PMC (area 6) ipsilaterally. It 
should be noted that, unlike for the right hand, no significant activation was found in the 
putamen (Figure 26B), even at a low threshold corresponding to p<0.01 uncorrected. 
	  
Figure 26: Location of the STN peaks for the left and right hand. 
The anatomical images shown are the average of the T1 acquisitions of all of the 
participants transformed into stereotaxic space. (A) SI vs. control condition. The location of 
the left significant STN activation is shown for the left hand in the left column and the 
location of the bilateral STN activation is shown for the right hand in the right column. (B) 
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SI vs. ET condition. The location of the bilateral STN activation is shown for the left hand in 
the left column; no such activation in observed when the right hand is used. 
 
3. SI vs. ET movements 
Right hand. When comparing the SI with the ET movements, for the right hand, 
significantly increased activity was found bilaterally in the mid-dorsolateral cortex (areas 9, 
46), in the cingulate cortex (at the intersection of areas 24 and 32), in the insula, and the 
PPC (area 7). In the ipsilateral side (i.e. right hemisphere), significant activition was found 
in the mid-dorsolateral PFC (area 46), the PPC (area 40), and the putamen (Figure 26C) 
(Table XVI). No significant activation was found in the STN (Figure 27B) even at a low 
threshold corresponding to p<0.01 uncorrected. 
Left hand. When the left hand was used, comparison of the SI with the ET movements 
demonstrated significantly increased activity bilaterally in the mid-dorsolateral PFC (areas 9, 
46), the cingulate cortex (areas 24, 32), the insula (area 13), and the PPC (area 7), as well as 
on the right PMC (area 6) and the right PPC (area 40). In the subcortical regions, significant 
activations were found bilaterally in the STN (Figure 27B), and in the thalamus, as well as 
the left putamen (Figure 26C) (Table XVI). 
 
4. Comparing left and right hands 
Self-Initiated movements condition. For the SI movements condition, significantly increased 
activity was found in the primary sensory region (areas 1, 2, 3), the motor cortex (area 4), 
the PPC (areas 7 and 40), and the SMA (area 6), all in the right hemisphere, but nowhere in 
the basal ganglia when comparing the left hand with the right one (Figure 26D) (Table 
XVII). When the right hand was compared with the left one (the reverse subtraction), 
significantly increased activity was found in the left hemisphere in the primary sensory 
region (areas 1, 2, 3), the motor cortex (area 4), the putamen (Figure 26D), and the thalamus, 
as well as in the right caudate nucleus (Table XVII). 
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Figure 27: Location of the dorsolateral PFC and caudate nucleus peaks for the left and 
right hand. 
The anatomical images shown are the average of the T1 acquisitions of all of the 
participants transformed into stereotaxic space. (A) SI vs. control condition. The location of 
the significant activation of the dorsolateral PFC and caudate nucleus is shown when using 
the left hand in the left column and when using the right hand in the right column. (B) SI vs. 
ET condition. The location of the bilateral dorsolateral PFC peaks is shown for each hand. 
 
ET movements condition. When comparing the left hand with the right hand during the ET 
movements condition, significantly increased activity was found in the right hemisphere in 
the primary sensory region (areas 1, 2, 3), the motor cortex (area 4), the PPC (area 40), the 
SMA (area 6), and, subcortically, in the right putamen (Figure 26E) and thalamus (Table 
XVIII). When the right hand was compared to the left one (the reverse substraction), 
significantly increased activity was found in the left hemisphere in the primary sensory 
region (areas 1, 2, 3), the motor cortex (area 4), the putamen (Figure 26E), and the thalamus, 
and, in the right hemisphere, in the SMA (area 6), and the caudate nucleus. 
Control condition. When comparing the left hand with the right hand during the control 
condition, significantly increased activity was found in the right hemisphere, in the medial 
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PFC (area 8), the primary sensory region (areas, 1, 2, 3), and the putamen (Figure 26F) 
(Table XIV). When the right hand was compared to the left one (the reverse subtraction), 
significantly increased activity was only found in the left primary sensory region (areas 1, 2, 
3), and, most importantly, not in the putamen (Figure 26F). 
 
Discussion 
 
The goal of this study was to further investigate the contributions of the putamen, the 
caudate nucleus, the STN, and the PFC during internally vs. externally generated novel 
movements when using the dominant and non-dominant hands separately. We will first 
discuss our results regarding the putamen, followed by the STN, and finally the PFC and 
caudate nucleus in the context of the dominant and non-dominant hands. 
 
Putamen 
We have previously proposed that the putamen plays an important role in the self-execution 
of non-routine actions (Monchi et al., 2006), which would imply that it is more required for 
the SI than the ET and control conditions. Several studies are in accord with this hypothesis 
(Jahanshahi et al., 1995; Jenkins et al., 2000; Weeks et al., 2001; Cunnington et al., 2002; 
Wiese et al., 2004). Indeed, we observe more putamen activity when comparing the SI and 
control conditions, as well as the SI and ET conditions. In the comparison of SI versus ET, 
however, we only obtained ipsilateral putamen activation with each hand as opposed to 
bilateral activation in SI versus control. In the study by Wiese et al. (2004), the authors only 
used the right hand for SI and ET movements, but they also observed ipsilateral putamen 
activation in the SI versus ET contrast. It seems, then, that a SI task, compared to the 
control, requires much more putamen, and therefore recruits them bilaterally. This then 
appears as an ipsilateral activation in our subtractions. The present results indicate that both 
the SI and ET movements recruit the putamen, in agreement with previous single-cell 
recordings in monkeys (Romo et al., 1992; Schultz & Romo, 1992), but that the ipsilateral 
putamen is even more solicited for a more complex (SI) task. Furthermore, it is interesting 
to note that for the ET versus control contrast, we only see putaminal activity (bilaterally) 
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when using the right hand. Our interpretation is that when the left hand is used, the control 
and the ET conditions have similar putamen requirement, due to a lack of automaticity in 
this hand, and therefore show no difference when subtracted from each other. This 
interpretation is substantiated by the fact that significantly more activation was found in the 
right putamen when comparing the left vs. the right hand but not in the left putamen for the 
reverse comparison (right vs. left) during the performance of the control condition. Finally, 
the comparison between the left and the right hand did not generate any significant 
activation in the right putamen for the SI condition while significant activation was found in 
the left putamen for the right vs. left hand for the same condition. This result may seem to 
contradict our initial hypothesis that the putamen is particularly involved in the self 
generation of a novel action, since this reflects the activity of a non-routine condition using 
the less proficient hand vs. the more proficient hand. However, it should be noted that 
significantly increased activity was found bilaterally for each hand separately, when 
comparing the SI to the control condition. Hence, for the SI condition, the putamen seems 
significantly recruited for both hands, and a non reported trend was found in the right 
putamen (t=2.6) when comparing the left to the right hand for the SI condition. These issues 
show the importance of carrying out additional studies using both hands separately. It may 
also be that our initial hypothesis needs to be further refined for the left hand. 
 
STN 
The STN has been proposed to enhance pallidal inhibition of the thalamus in order to inhibit 
unwanted (motor) responses (Mink 1996; Nambu et al., 2002). Furthermore, lesions of the 
STN lead to violent uncontrolled movements called ballism (Hamani et al., 2004). During 
the performance of a Go/No-Go task, Aron and Poldrack (2006) proposed that the STN is 
involved in blocking unwanted responses by inhibiting thalamo-cortical output. 
Furthermore, another study compared differences in stop-signal response time (SSRT) 
inhibition, and observed increased STN activation in subjects with longer SSRTs (Ray et al., 
2008). In the present study, the STN was more involved in the SI condition as compared to 
the control with both hands, and in the SI condition as compared to the ET condition with 
the left hand. This would imply that one requires more inhibition for unwanted movements 
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for the SI task than the other two. In the ET and the control tasks, the computer indicates to 
the subject with button to press, so there are presumably no movements to inhibit. In the SI 
task, however, participants need to avoid pressing the same button twice in a row and to 
repeat simple sequences, both of which requires the more straightforward movements. This 
explains why the STN is most recruited in the SI condition. When comparing the SI to the 
ET condition, however, we only observe STN activation when using the left hand. A 
possible interpretation is that in those individuals, via lifelong training, the right dominant 
hand is less prone to unwanted errors (such as a repetitions in this task), and for that reason 
may require less inhibition from the STN.  
 
Dominant and non-dominant hands 
Many studies focus their attention to right-handed movements only (Jenkins et al., 2000; 
Cunnington et al., 2002), of left-handed movements only (Taniwaki et al., 2006), or 
compared the right-handed movements to a simple left-handed movement (Mattay et al., 
1998). The main purpose of our study was to investigate the difference when healthy right-
handed subjects make equivalent movements with their right as well as their left hands. 
First, in the SI condition, when the subjects used their right hand (compared to the left), 
significant activation was observed in the striatum (putamen and caudate nucleus) but not in 
PFC (Table XVII). Conversely, when they used their left hand (compared to the right), 
significant activation occurred in the PFC and PPC but not in the striatum. Second, for the 
ET condition (Table XVIII) we observed putamen activation when subjects use both the 
right and left hands, and PPC activation only when they use their left hand (as compared to 
the right). Finally, for the control condition (Table XIX), both medial PFC and putamen 
activation was observed only when participants used their left hand, but not when they used 
their right one. Taken together, these results indicate that the right hand requires 
significantly less cortical processing than the left one across conditions. The left hand, does 
not produce button presses as automatically as the right hand, and therefore requires more 
cognitive effort in order to plan, select, and execute movements. One study showed an 
increase in cortical activations of right-handers during right and left index movements, but 
this was only in comparison to left-handed subjects, and not within the populations (Kloppel 
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et al., 2007). It is interesting to note that even in our control condition the PFC was 
recruited significantly more for the left hand than for the right one. This indicates that even 
the repetition of simple movements require a fair amount of planning in order to be 
executed properly with an untrained limb. The fact that both the putamen and the PFC are 
more solicited for the left hand compared to the right hand in the control condition gives 
further support to our earlier observation that the control and ET condition are relatively 
complex for the left hand, and therefore recruit the putamen at similar levels leading to no 
significant difference in activation between the two conditions. We propose that, with 
respect to the putamen involvement, variability in task condition is more important for the 
dominant hand than for the non-dominant hand because the lack of training in the left hand 
is stronger than the difference between conditions. Furthermore, cortical recruitment is more 
necessary for the non-dominant hand because of this lack of training. 
Recent fMRI studies in humans have suggested that the caudate nucleus is particularly 
involved when manipulation is required in working memory to plan a novel response 
(Lewis et al., 2004; Monchi et al., 2006). In the present study, when using the right hand, 
caudate nucleus activation was found during SI conditions compared with the control 
condition when either hand was used. Our group has previously observed significant 
increases in activation in the caudate nucleus when SI retrieval and planning was required to 
perform a set-shift as opposed to applying the same rule in the context of a card-sorting task 
(Monchi et al., 2006). SI movements contain some of the same demands as the planning of 
a set-shift or multiple new moves (considering a distinct button press as a simple action) 
where the caudate nucleus has been shown to play an important role (Monchi et al. 2001, 
2006). Furthermore, in the present study, the caudate nucleus was only significantly 
activated in synchrony with the mid-dorsolateral PFC (Table XX). This is in agreement with 
the theory that proposes that these two structures are part of the ‘cognitive’ cortico-striatal 
loop proposed by Alexander et al. (1986). Importantly, a previous Positron Emission 
Tomography study has shown the involvement of the caudate nucleus together with the 
dorsolateral PFC in the execution of a complex planning task (Owen et al., 1996). 
Interestingly, Cunnington et al. (2002) did not report significant activation of the caudate 
nucleus nor the PFC using fMRI while subjects performed SI finger movements using the 
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right hand. This is likely due to the fact that, in their task, the sequential finger movements 
always followed a simple pattern (index-middle-index finger). In the SI condition, then, 
while participants had to initiate their movements, they did not have to track their previous 
moves nor plan their next one like those in the present study had to.  
 
Conclusion 
First, our results show that the putamen is particularly involved for the execution of non-
routine movements for either hand, especially if those are SI, as these require more planning. 
Furthermore, we propose that, for right-handed people performing fine movements, as far as 
putamen involvement is concerned, the lack of proficiency of the non-dominant hand may 
prevail over other task demands. Specifically, the putamen seems to be more required for 
simple tasks when using the left hand than the right hand, but its activity does not increase 
as much for the left than the right hand when the tasks get more complex. Second, the 
patterns of activity observed within the STN provide further evidence of its involvement in 
movement selection by inhibiting concurring motor events. Finally, the difference of the 
cortical patterns of activity observed in the left hand compared with the right one indicate 
that tasks involving cognitive motor control may be harder for the non-dominant hand than 
for the dominant one and therefore solicit a larger amount of cortical areas. These results 
raise interesting questions about cortical and subcortical functional interactions during the 
performance of tasks with both cognitive and motor components, in patients with 
asymmetrical movement disorders such as PD. 
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Table XIV: Activity peaks associated with SI movements, compared with the control 
condition 
 
The coordinates (x, y, z) are in standard MNI stereotaxic space. Abbreviations for Tables 
1–7: BA, Brodmann area; DLPFC, dorsolateral prefrontal cortex; ET, externally triggered 
(movements); L ⁄ R, left ⁄ right hemispheres; PMC, premotor cortex; PPC, posterior parietal 
cortex; sc, same cluster; SI, self-initiated (movements). *P < 0.001 non-corrected for 
multiple comparisons. 
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Table XV: Activity peaks associated with ET movements, compared with the control 
condition 
 
Abbreviations as in table XIV. 
 
Table XVI: Activity peaks associated with SI movements, compared with ET 
movements 
 
Abbreviations as in table XIV. 
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Table XVII: Activity peaks associated with SI movements, comparing one hand with 
the other 
 
Abbreviations as in table XIV. 
 
Table XVIII: Activity peaks associated with ET movements, comparing one hand with 
the other 
 
Abbreviations as in table XIV. 
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Table XIX: Activity peaks associated with control movements, comparing one hand 
with the other 
 
Abbreviations as in table XIV. 
 
Table XX: Summary of the major results: (a) left and right hand activations 
separately, (b) comparing right and left hand activations 
 
SAL, significant activation in the left hemisphere; SAR, significant activation in the right 
hemisphere; SBA, significant bilateral activation; Other abbreviations as in Table XIV. 
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Appendix III 
 In this appendix we have included the UPDRS form used for the symptom 
evaluation in the chapters of this thesis. Table XXI also lists the individual left and right 
UPDRS scores for the 12 patients with PD.  
To calculate the UPDRS scores for the left and right side of the body (chapter 4), we 
have used the following subsections of the UPDRS: 3 (tremor at rest), 4 (postural tremor), 
5b-e (rigidity), 6 (finger taps), 7 (hand movements), 8 (alternating hand movements), and 9 
(leg agility). 
 
Table XXI: Sum of left and right side symptoms for individual patients ON and OFF 
medication 
 
ON OFF 
Patient Left Right Left  Right 
1 14 15 13 15 
2 7.5 5 11.5 7 
3 10 5.5 10.5 8 
4 7 7.5 11 10.5 
5 7 3.5 9 5 
6 12 6.5 16.5 11.5 
7 9 8.5 9 7 
8 8 5 14 10.5 
9 8 7.5 9.5 10.5 
10 5.5 11.5 4.5 14 
11 13 6.5 13 11 
12 7.5 2 9.5 8.5 
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